Amenorrhoea

N14_AMENORRHEAPRIM

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule only females	293218
2. Check conditions None	293218
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N91.0, N91.1, N91.2 Hospital discharge: ICD-9 — 6260 Hospital discharge: ICD-8 — 6260 Cause of death: ICD-10 — N91.0, N91.1, N91.2 Cause of death: ICD-9 — 6260 Cause of death: ICD-8 — 6260 2 out of 7 registries used, show all original rules.	3295
4. Check minimum number of events None	3295
5. Include endpoints None	3295
6. Filter based on genotype QC (FinnGen only)	3161

Control definitions (FinnGen only)

Control exclude: N14_FEMALEGENNONINF

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	N14_AMENORRHEAPRIM
CONTROL_EXCLUDE	N14_FEMALEGENNONINF
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N91[0-2]
HD_ICD_9	6260
HD_ICD_8	6260
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N91[0-2]
COD_ICD_9	6260
COD_ICD_8	6260
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Amenorrhoea based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Primary amenorrhea

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	23028	23028	-
Only index persons	22269	22269	-
Unadjusted period prevalence (%)
Whole population	0.66	0.66	-
Only index persons	0.82	0.82	-
Median age at first event (years)
Whole population	-	23.76	-
Only index persons	-	23.55	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3161	3161	-
Unadjusted period prevalence (%)	1.12	1.12	-
Median age at first event (years)	26.58	26.58	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3295: Matched controls
32950

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

7.9

307.7

912

1521

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

19.7

307.7

272

150

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

4.8

307.7

1729

6144

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

16.1

307.7

394

275

G03DB01

ATC

dydrogesterone; oral

9.6

307.7

1506

2655

N97.9

ICD-10 Finland

Female infertility, unspecified

47.6

307.7

399

Z35.0

ICD-10 Finland

Supervision of pregnancy with history of infertility

29.8

307.7

233

62600

ICD-8 Finland

Disorders of menstruation, Absent

+∞

307.7

379

LCA06

NOMESCO Finland

Biopsy of endometrium

11.5

307.7

451

448

LA2AE

NOMESCO Finland

Ultrasound examination of ovarian cyst

214.0

307.7

201

N91.2

ICD-10 Finland

Amenorrhoea, unspecified

34.7

307.7

340

109

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

13.3

307.7

401

340

F50.0

ICD-10 Finland

Anorexia nervosa

21.2

307.7

316

164

N91.1

ICD-10 Finland

Secondary amenorrhoea

437.3

307.7

2467

223

N97.0

ICD-10 Finland

Female infertility associated with anovulation

277.6

307.7

413

N91.0

ICD-10 Finland

Primary amenorrhoea

813.8

306.4

297

N95.1

ICD-10 Finland

Menopausal and female climacteric states

+∞

291.0

275

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

8.4

245.4

337

441

LAA10

NOMESCO Finland

Percutaneous or transvaginal puncture and recovery of oocyte

83.9

243.6

129

G03GA02

ATC

human menopausal gonadotrophin; parenteral

16.0

243.6

212

141

G03FB08

ATC

dydrogesterone and estrogen; systemic

7.3

240.6

376

570

N84.0

ICD-10 Finland

Polyp of corpus uteri

39.4

240.1

147

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

4.4

212.8

612

1610

121

Kela drug reimbursment

Severe hypofunction of sexual glands

15.7

209.6

184

124

G03GA01

ATC

chorionic gonadotrophin; parenteral

9.9

206.7

245

265

N91.4

ICD-10 Finland

Secondary oligomenorrhoea

38.8

206.7

127

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

8.2

205.9

286

378

F50.1

ICD-10 Finland

Atypical anorexia nervosa

14.8

199.1

180

128

N97.8

ICD-10 Finland

Female infertility of other origin

65.0

194.4

107

G03GA05

ATC

follitropin alfa; parenteral

12.5

181.4

182

154

G03FB06

ATC

medroxyprogesterone and estrogen; systemic

5.9

175.5

335

618

E22.1

ICD-10 Finland

Hyperprolactinaemia

15.2

174.1

155

107

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

5.0

171.8

407

910

N87.0

ICD-10 Finland

Mild cervical dysplasia

46.6

161.7

F50.9

ICD-10 Finland

Eating disorder, unspecified

7.9

160.6

227

305

ULC02

NOMESCO Finland

Hysteroscopy

10.1

158.1

183

191

E28.3

ICD-10 Finland

Primary ovarian failure

27.9

152.0

103

X05

ICPC

Menstruation absent/scanty

6.9

151.6

242

372

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

65.5

150.9

TLC00

NOMESCO Finland

Insertion of intrauterine device

4.8

141.1

344

784

N95.0

ICD-10 Finland

Postmenopausal bleeding

13.4

135.4

129

100

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

2.5

132.0

1172

5874

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

15.9

128.6

111

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.6

117.3

924

4337

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

+∞

116.3

111

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

3.0

113.7

613

2365

TLW00

NOMESCO Finland

Insemination

+∞

113.2

108

XLA10, ,

NOMESCO Finland

5.5

110.0

222

428

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.4

107.8

284

685

N80.1

ICD-10 Finland

Endometriosis of ovary

32.0

106.4

H01CC01

ATC

ganirelix; parenteral

7.8

104.3

147

196

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

12.2

104.2

105

G03DA02

ATC

medroxyprogesterone; systemic

4.2

101.3

287

731

N81.6

ICD-10 Finland

Rectocele

11.9

100.0

102

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.5

93.9

361

1134

LCB25

NOMESCO Finland

Hysteroscopic excision of lesion

10.0

89.6

103

106

N05AH04

ATC

quetiapine; oral

2.4

89.5

789

3838

N81.1

ICD-10 Finland

Cystocele

12.6

86.6

TLW12

NOMESCO Finland

Insertion of frozen embryo

+∞

85.8

G03GA06

ATC

follitropin beta; parenteral

8.5

85.4

111

134

N05AH03

ATC

olanzapine; systemic

3.3

83.3

336

1085

N05AX08

ATC

risperidone; systemic

3.4

81.5

316

995

H01CA02

ATC

nafarelin; nasal

10.1

81.0

N97.4

ICD-10 Finland

Female infertility associated with male factors

281.4

80.9

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

80.1

708

3430

G03DA04

ATC

progesterone; systemic, rectal, vaginal

6.9

79.4

124

185

ULA02

NOMESCO Finland

Kolposcopy

3.0

79.3

388

1403

8113

FHL

Fractional scraping

11.7

76.8

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

76.1

585

2657

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

76.0

1347

8500

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

76.0

1027

5881

A10BA02

ATC

metformin; oral

2.4

75.1

597

2752

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

22.9

74.1

TLW10

NOMESCO Finland

Transfer of fresh embryo

375.7

74.0

H03AA01

ATC

levothyroxine sodium; systemic

2.1

73.3

865

4696

N06AB03

ATC

fluoxetine; oral

2.5

71.5

499

2162

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

3.1

70.4

314

1074

P86

ICPC

Anorexia nervosa/bulimia

9.2

70.3

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.7

69.6

235

675

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

6.6

67.8

111

174

N87.1

ICD-10 Finland

Moderate cervical dysplasia

344.1

67.8

N03AX16

ATC

[U] pregabalin

2.3

65.4

601

2936

JAH01

NOMESCO Finland

Laparoscopy

4.7

64.9

153

336

101

Kela drug reimbursment

Anterior pituitary hypofunction

15.2

64.9

N05AX12

ATC

aripiprazole; systemic

3.2

64.7

273

903

N80.9

ICD-10 Finland

Endometriosis, unspecified

12.6

64.2

H02AB09

ATC

hydrocortisone; systemic

5.2

64.0

134

266

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.2

63.8

660

3381

E23.00

ICD-10 Finland

Panhypopituitarism

23.3

63.6

N92.4

ICD-10 Finland

Excessive bleeding in the premenopausal period

9.7

62.3

Z3231

NOMESCO Finland

Registered nurse

2.0

61.9

818

4591

6260A

ICD-9 Finland

Disorders of menstruation and other abnormal bleeding from female genital tract, Absence of menstruation

+∞

61.6

N04BC06

ATC

cabergoline; oral

10.5

60.7

B02AA02

ATC

tranexamic acid; systemic

2.4

59.3

447

1997

N03AX09

ATC

lamotrigine; oral

3.0

58.9

284

1013

A06AD11

ATC

lactulose; oral

2.8

58.5

317

1205

N05AA02

ATC

levomepromazine; systemic

4.4

58.3

148

345

N02AX02

ATC

tramadol; systemic, rectal

1.9

57.9

987

6026

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

3.7

57.8

194

554

N03AG01

ATC

valproic acid; systemic, rectal

3.2

56.9

239

787

G03GB02

ATC

clomifene; oral

6.3

56.7

159

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.3

56.4

468

2179

N80.0

ICD-10 Finland

Endometriosis of uterus

19.8

55.5

N06AX16

ATC

venlafaxine; oral

2.2

55.3

579

2964

N06AX11

ATC

mirtazapine; oral

1.9

55.3

1034

6484

N06AB04

ATC

citalopram; systemic

2.1

55.0

663

3581

N05CF01

ATC

zopiclone; oral

2.0

54.7

784

4502

Z2221

NOMESCO Finland

Medical doctor

1.9

54.5

939

5733

Z3226

NOMESCO Finland

Physiotherapist

2.2

54.3

547

2757

LA2HE

NOMESCO Finland

Repeated measurement of ovarian cyst

189.8

54.1

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

2.5

53.8

375

1613

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.1

52.6

227

759

AA1AD

NOMESCO Finland

CT of head and brain

2.2

52.5

536

2713

N05AH02

ATC

clozapine; systemic

4.7

52.2

124

274

N87.2

ICD-10 Finland

Severe cervical dysplasia, not elsewhere classified

139.8

52.0

UJF32

NOMESCO Finland

Coloscopy

2.2

51.6

529

2680

G03FB05

ATC

norethisterone and estrogen; systemic

2.9

51.0

253

915

N05BA06

ATC

lorazepam; systemic, sublingual

3.8

50.9

162

446

N05CD07

ATC

temazepam; oral

3.1

50.1

214

711

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

50.0

613

3320

N91.5

ICD-10 Finland

Oligomenorrhoea, unspecified

8.7

49.5

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

4.6

48.9

117

260

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.9

48.8

248

909

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.1

48.5

209

698

F50.2

ICD-10 Finland

Bulimia nervosa

5.4

48.2

182

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

48.2

971

6183

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

48.2

332

1418

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.3

47.6

186

585

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

474.5

47.4

E66.8

ICD-10 Finland

Other obesity

2.7

46.8

265

1028

N05BA01

ATC

diazepam; systemic, rectal

2.4

46.3

349

1551

L68.0

ICD-10 Finland

Hirsutism

6.3

45.8

124

LAC01

NOMESCO Finland

Laparoscopic excision of ovarian cyst

9.8

45.7

N05BA04

ATC

oxazepam; oral

1.8

45.4

836

5164

N92.5

ICD-10 Finland

Other specified irregular menstruation

2.9

45.3

222

797

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

45.0

675

3905

N83.1

ICD-10 Finland

Corpus luteum cyst

15.2

44.3

P01AB01

ATC

metronidazole; oral, rectal

1.7

44.2

1250

8715

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

44.0

988

6460

G03DC02

ATC

norethisterone; oral

2.5

44.0

289

1205

N06AX21

ATC

duloxetine; oral

2.3

43.9

379

1785

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

43.9

961

6238

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

43.5

421

2077

LAF01

NOMESCO Finland

Laparoscopic unilateral salpingo-oophorectomy

7.7

42.9

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

42.5

391

1890

Z2446

NOMESCO Finland

Social worker

2.6

42.4

263

1066

LCA10

NOMESCO Finland

Curettage of body of uterus

7.3

42.4

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.9

42.0

125

328

G03FB09

ATC

levonorgestrel and estrogen; systemic

5.4

41.6

154

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.8

41.3

869

5559

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.3

41.2

164

522

N03AX12

ATC

[U] gabapentin; oral

2.2

41.1

395

1942

8077/2-C53.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of cervix uteri

12.2

41.1

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

212.6

40.9

A02BC02

ATC

pantoprazole; systemic

1.6

40.9

1756

13535

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

2.6

40.7

248

997

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.2

40.6

359

1706

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

6.4

40.6

106

J01MA02

ATC

ciprofloxacin; systemic

1.7

40.1

889

5766

Z71.8

ICD-10 Finland

Other specified counselling

1.7

40.0

1159

8078

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

39.9

854

5483

F50.8

ICD-10 Finland

Other eating disorders

6.3

39.8

108

N97.1

ICD-10 Finland

Female infertility of tubal origin

141.8

39.8

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

39.7

1117

7722

C03CA01

ATC

furosemide; systemic

2.2

39.6

385

1900

W15

ICPC

Infertility/subfertility female

8.2

39.3

N85.0

ICD-10 Finland

Endometrial glandular hyperplasia

58.3

39.3

ZY010

NOMESCO Finland

Hospital outpatient

2.5

39.2

271

1156

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.0

39.2

455

2400

UKC02

NOMESCO Finland

Cystoscopy

2.9

39.2

194

700

N05AF03

ATC

chlorprothixene; systemic

4.1

39.1

109

273

103

Kela drug reimbursment

Diabetes, insulin-treated

2.0

39.0

465

2476

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

5.2

38.9

160

N91

ICD-10 Finland

Absent, scanty and rare menstruation

8.8

38.4

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.1

38.4

162

L02AE01

ATC

buserelin; implant, nasal, parenteral

14.1

38.2

N83.0

ICD-10 Finland

Follicular cyst of ovary

9.5

38.0

L02BG04

ATC

letrozole; oral

2.6

37.7

229

918

N03AE01

ATC

clonazepam; systemic

3.1

37.7

161

534

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

37.7

258

1095

LAC21

NOMESCO Finland

Laparoscopic destruction of lesion of ovary

15.1

37.4

F50.3

ICD-10 Finland

Atypical bulimia nervosa

5.4

37.3

140

N05AB03

ATC

perphenazine; systemic, rectal

3.4

37.3

134

400

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.8

37.1

189

692

L17

ICPC

Foot/toe symptom/complaint

1.7

37.1

835

5421

R4190

NOMESCO Finland

Nutritional therapy

3.1

36.8

163

552

LEF00

NOMESCO Finland

Anterior colporraphy with sutures for primary cystocele

101.2

36.8

6266A

ICD-9 Finland

Disorders of menstruation and other abnormal bleeding from female genital tract, Metrorrhagia

+∞

36.5

J01FF01

ATC

clindamycin; systemic

1.8

36.5

737

4637

N94.1

ICD-10 Finland

Dyspareunia

5.5

36.5

132

RD210, ,

NOMESCO Finland

4.1

36.5

102

256

R51.80

ICD-10 Finland

Headache

1.8

36.4

622

3725

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.2

36.2

240

J02AC01

ATC

fluconazole; systemic

1.6

36.2

1456

10932

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

36.1

428

2271

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

36.0

616

3688

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.8

36.0

185

681

Z31.2

ICD-10 Finland

In vitrofertilization

98.7

35.8

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

35.8

289

1320

N06AB06

ATC

sertraline; oral

2.0

35.7

473

2607

R53

ICD-10 Finland

Malaise and fatigue

1.7

35.5

790

5102

ZYC01

NOMESCO Finland

Remote contact by phone

2.6

35.5

224

915

N06AA09

ATC

amitriptyline; systemic

2.6

35.1

209

829

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

35.1

426

2277

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.6

35.1

220

895

N93.9

ICD-10 Finland

Abnormal uterine and vaginal bleeding, unspecified

4.1

34.9

238

S18

ICPC

Laceration/cut

1.6

34.8

1100

7774

T90

ICPC

Diabetes non-insulin dependent

2.1

34.7

371

1894

E66.9

ICD-10 Finland

Obesity, unspecified

2.9

34.7

167

593

N06AB10

ATC

escitalopram; oral

1.7

34.7

858

5698

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.5

34.6

225

932

LBF01

NOMESCO Finland

Laparoscopic perfusion of Fallopian tube

51.9

34.5

62660

ICD-8 Finland

Disorders of menstruation, Intermenstrual bleeding

+∞

34.4

C07AB07

ATC

bisoprolol; oral

1.7

34.2

787

5121

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

34.2

289

1345

H02AB06

ATC

prednisolone; systemic

1.6

34.2

1229

8950

C07AA05

ATC

propranolol; systemic

1.7

34.1

723

4600

K59.09

ICD-10 Finland

Constipation, unspecified

3.1

33.9

149

503

M79.6

ICD-10 Finland

Pain in limb

1.6

33.8

1218

8869

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

33.8

532

3100

N05AN01

ATC

lithium; oral

3.5

33.7

120

356

Z3229

NOMESCO Finland

Other healthcare associate professional

2.5

33.6

223

932

Z2445

NOMESCO Finland

Psychologist

2.6

33.6

205

823

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

5.7

33.5

110

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.3

33.2

125

384

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

33.0

538

3168

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

32.5

308

1500

K59.1

ICD-10 Finland

Functional diarrhoea

2.8

32.5

169

626

AA400

NOMESCO Finland

Electroconvulsive therapy

6.0

32.5

R63.0

ICD-10 Finland

Anorexia

10.4

32.5

62601, ,

ICD-8 Finland

+∞

32.3

R50.9

ICD-10 Finland

Fever, unspecified

1.9

32.3

445

2482

G02CB01

ATC

bromocriptine; systemic

3.8

32.1

262

LAA06

NOMESCO Finland

Transvaginal puncture of ovarian cyst

114.5

31.7

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

31.5

408

2228

62699

ICD-8 Finland

Disorders of menstruation, Other

+∞

31.3

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.1

31.2

218

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.9

31.1

424

2353

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.4

31.1

111

330

LCD10

NOMESCO Finland

Vaginal hysterectomy

7.2

30.9

R06.0

ICD-10 Finland

Dyspnoea

1.7

30.9

606

3762

LCA16

NOMESCO Finland

Destruction of endometrium

315.8

30.9

C03DA01

ATC

spironolactone; oral

2.5

30.7

207

871

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.7

30.6

176

686

R11

ICD-10 Finland

Nausea and vomiting

2.1

30.4

317

1600

A10AB05

ATC

insulin aspart; parenteral

2.4

30.4

219

950

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

3.4

30.4

110

330

D64.9

ICD-10 Finland

Anaemia, unspecified

2.6

30.3

188

761

A10AE04

ATC

insulin glargine; parenteral

2.4

30.3

225

990

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

30.2

1156

8479

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

30.1

221

967

N04AA02

ATC

biperiden; systemic

4.3

30.1

185

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

30.1

464

2680

N93.8

ICD-10 Finland

Other specified abnormal uterine and vaginal bleeding

5.2

30.0

118

A02BC05

ATC

esomeprazole; systemic

1.6

29.8

943

6617

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

29.6

543

3303

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.0

29.6

131

444

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

29.6

267

1275

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

29.4

467

2721

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

29.3

204

871

62800

ICD-8 Finland

Sterility, female, Sterilitas primaria

+∞

29.2

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

29.1

265

1269

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

29.1

657

4232

ZXE00

NOMESCO Finland

One hour or less

1.5

29.0

1146

8448

N05AF05

ATC

zuclopenthixol; systemic

7.3

28.8

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

28.8

529

3217

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4.7

28.7

142

M81.8

ICD-10 Finland

Other osteoporosis

7.4

28.4

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.5

28.3

191

804

E66.00

ICD-10 Finland

Metabolic syndrome

2.8

28.2

143

522

XCK10

NOMESCO Finland

Photography of fundus of eye

2.4

28.1

204

888

E66.0

ICD-10 Finland

Obesity due to excess calories

6.6

28.1

R42

ICD-10 Finland

Dizziness and giddiness

1.8

28.0

530

3248

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

10.4

28.0

G44.2

ICD-10 Finland

Tension-type headache

1.8

28.0

487

2913

N05AD01

ATC

haloperidol; systemic

3.8

27.9

227

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

4.2

27.8

179

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.0

27.6

122

413

N84.1

ICD-10 Finland

Polyp of cervix uteri

7.1

27.6

H01AC01

ATC

somatropin; parenteral

10.1

27.4

F61.0

ICD-10 Finland

Mixed personality disorders

3.6

27.3

249

E0000UV, ,

ATC

1.5

27.1

1366

10561

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

5.7

26.9

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

26.9

436

2552

K59.0

ICD-10 Finland

Constipation

2.7

26.8

143

537

H02AB07

ATC

prednisone; oral

2.0

26.7

321

1705

R33

ICD-10 Finland

Retention of urine

3.7

26.6

230

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.3

26.5

101

P72

ICPC

Schizophrenia

3.7

26.2

237

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

26.2

241

1158

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

26.0

26.2

N85.1

ICD-10 Finland

Endometrial adenomatous hyperplasia

+∞

26.1

6202X

ICD-9 Finland

Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Other and unspecified ovarian cyst

+∞

26.1

XKD00

NOMESCO Finland

Uroflowmetry

3.3

26.0

307

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

25.9

231

1096

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.5

25.9

162

658

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

25.9

188

818

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

4.3

25.8

159

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

25.8

206

935

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

25.7

339

1857

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

25.7

209

956

D01

ICPC

Abdominal pain/cramps general

1.8

25.6

462

2789

R07.3

ICD-10 Finland

Other chest pain

2.2

25.5

230

1096

B01AB05

ATC

enoxaparin; parenteral

1.6

25.5

666

4438

Z01.7

ICD-10 Finland

Laboratory examination

1.8

25.4

447

2677

N05CF02

ATC

zolpidem; oral

1.8

25.3

467

2835

N76.0

ICD-10 Finland

Acute vaginitis

1.8

25.3

383

2192

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.9

25.2

120

424

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.6

25.2

239

N03AF01

ATC

carbamazepine; oral, rectal

2.9

25.1

119

419

Z31.1

ICD-10 Finland

Artificial insemination

+∞

25.0

N97

ICD-10 Finland

Female infertility

7.0

25.0

A02BC03

ATC

lansoprazole; oral

1.7

25.0

555

3545

A02BC01

ATC

omeprazole; systemic

1.6

24.9

653

4350

R63.4

ICD-10 Finland

Abnormal weight loss

3.2

24.9

310

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.4

24.9

170

720

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

24.9

266

1354

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

24.7

490

3037

LBF00

NOMESCO Finland

Perfusion of Fallopian tube

131.0

24.6

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

24.6

471

2889

TLC02

NOMESCO Finland

Simple extraction of IUD

2.5

24.5

155

633

M54.5

ICD-10 Finland

Low back pain

1.5

24.5

1058

7884

J01MA12

ATC

levofloxacin; systemic

1.9

24.4

350

1970

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

24.0

261

1336

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.8

24.0

121

441

LEF13

NOMESCO Finland

Colpoperineoplasty and vaginal hysterectomy

+∞

24.0

R55

ICD-10 Finland

Syncope and collapse

2.1

23.9

238

1179

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.4

23.9

173

752

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

23.9

206

965

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

4.8

23.9

111

J01DB01

ATC

cefalexin; oral

1.6

23.8

2617

23392

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.1

23.7

222

1074

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

23.6

326

1811

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.8

23.6

193

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.1

23.5

316

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.4

23.4

157

660

R4110

NOMESCO Finland

Physiotherapy

1.6

23.3

643

4330

G47.3

ICD-10 Finland

Sleep apnoea

1.8

23.3

369

2140

N05AE04

ATC

ziprasidone; systemic

5.0

23.2

102

T08

ICPC

Weight loss

4.1

23.1

160

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

23.0

132

514

R52.2

ICD-10 Finland

Other chronic pain

3.1

23.0

320

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.6

22.9

133

521

A10BJ06

ATC

semaglutide; parenteral

2.9

22.9

109

385

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

6.9

22.9

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.4

22.9

157

666

L02AE02

ATC

leuprorelin; implant, parenteral

4.0

22.6

167

RS220, ,

NOMESCO Finland

4.3

22.5

137

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

22.5

348

2002

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

22.5

295

1611

A10BJ05

ATC

dulaglutide; parenteral

4.7

22.4

109

WX402

NOMESCO Finland

General anaesthesia

1.6

22.4

553

3622

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

22.3

445

2757

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.5

22.3

148

619

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

22.3

174

782

A02BA02

ATC

ranitidine; systemic

1.9

22.3

318

1785

LDA10

NOMESCO Finland

Curettage of cervix uteri

2.7

22.1

123

472

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

22.1

117

438

6262A

ICD-9 Finland

Disorders of menstruation and other abnormal bleeding from female genital tract, Excessive or frequent menstruation[HYPERMENORRHOEA]

+∞

21.9

N02AA05

ATC

oxycodone; systemic

2.0

21.8

250

1303

T05

ICPC

Feeding problem of adult

3.7

21.7

190

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

21.6

233

1188

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

21.6

174

792

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

21.6

666

4594

N06AX03

ATC

mianserin; oral

2.8

21.6

109

398

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

21.5

179

826

G02CB03

ATC

cabergoline; oral

5.8

21.5

WX002

NOMESCO Finland

Sedation and analgesia

1.8

21.5

379

2267

H3603, E103,

ICD-10 Finland

4.6

21.5

113

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

21.4

349

2041

LEB00

NOMESCO Finland

Biopsy of vagina

5.6

21.3

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

21.3

226

1146

N05AA01

ATC

chlorpromazine; systemic, rectal

4.8

21.3

102

G03GA30

ATC

gonadotropins - combinations; systemic

19.0

21.2

TKC20

NOMESCO Finland

Catheterisation of bladder

2.8

21.1

110

408

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

21.1

277

1512

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.2

21.1

258

T89

ICPC

Diabetes insulin dependent

2.4

21.0

148

636

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.6

20.9

617

4209

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.8

20.8

352

2079

A10AE06

ATC

insulin degludec; parenteral

2.7

20.6

114

436

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.6

20.6

197

G04CA02

ATC

tamsulosin; oral

3.7

20.6

183

LA2JE

NOMESCO Finland

Follow-up of menstrual cycle with repeated measurement of ovarian cyst

211.3

20.6

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.7

20.6

109

408

N81.5

ICD-10 Finland

Vaginal enterocele

110.7

20.6

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

20.6

243

1280

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

5.5

20.5

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.8

20.4

100

359

N05BA12

ATC

alprazolam; oral

2.0

20.2

233

1217

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.7

20.2

890

11590

LCB98

NOMESCO Finland

Other transluminal endoscopic excision of lesion of uterus

8.4

20.1

N02BE01

ATC

paracetamol; systemic, rectal

1.5

20.1

2637

23867

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.3

20.0

148

650

N80

ICD-10 Finland

Endometriosis

7.3

19.9

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.8

19.9

353

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

4.4

19.9

116

A02BX02

ATC

sucralfate; oral

3.6

19.8

183

N06AX12

ATC

bupropion; oral

1.8

19.8

301

1720

TLW14

NOMESCO Finland

ICSI

+∞

19.8

N98.1

ICD-10 Finland

Hyperstimulation of ovaries

+∞

19.8

N95.8

ICD-10 Finland

Other specified menopausal and perimenopausal disorders

+∞

19.8

J01EA01

ATC

trimethoprim; systemic

1.5

19.8

826

6061

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

19.8

235

1240

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

19.8

527

3508

N06AB05

ATC

paroxetine; oral

2.2

19.7

177

842

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

19.7

225

1172

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

19.6

169

792

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

19.6

187

912

N91.3

ICD-10 Finland

Primary oligomenorrhoea

17.8

19.5

R52.9

ICD-10 Finland

Pain, unspecified

1.9

19.5

251

1361

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

3.0

19.5

297

N90.8

ICD-10 Finland

Other specified noninflammatory disorders of vulva and perineum

6.2

19.4

1410

FHL

Laparoscopy

4.6

19.4

J01CA08

ATC

pivmecillinam; oral

1.4

19.4

1603

13306

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.5

19.3

117

469

R60.9

ICD-10 Finland

Oedema, unspecified

2.5

19.3

122

499

N03AX11

ATC

topiramate; oral

2.6

19.2

112

440

A10AC01

ATC

insulin (human); parenteral

2.0

19.2

211

1083

ZXD20

NOMESCO Finland

Day surgery

1.8

19.2

298

1715

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.9

19.2

316

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

19.2

746

5393

P29

ICPC

Psychological sympt/compl other

1.7

19.1

355

2152

L03

ICPC

Low back symptom/complaint

1.5

19.1

840

6223

R02

ICPC

Shortness of breath/dyspnoea

1.8

19.0

313

1832

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.4

19.0

198

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

19.0

940

7118

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

19.0

199

1004

A01AB09

ATC

miconazole; local oral

2.0

19.0

203

1032

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

19.0

568

3881

A10AE05

ATC

insulin detemir; parenteral

2.3

18.9

152

692

C10AC01

ATC

colestyramine; oral

3.1

18.8

250

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.0

18.8

130

62620

ICD-8 Finland

Disorders of menstruation, Excessive

+∞

18.8

61520

ICD-8 Finland

Other diseases of ovary and Fallopian tube, Cysta (cystis) follicularis ovarii (retentio)

+∞

18.8

E23.05

ICD-10 Finland

Lack of TSH

8.1

18.8

D11

ICPC

Diarrhoea

1.6

18.7

449

2909

ZY000

NOMESCO Finland

Hospital inpatient

3.3

18.7

220

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

18.7

482

3179

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.7

18.7

162

A01

ICPC

Pain general/multiple sites

1.9

18.7

233

1250

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.0

18.7

288

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

18.6

176

855

M79.1

ICD-10 Finland

Myalgia

1.6

18.6

457

2981

SPAT1234

SPAT

Support of social functional capacity

2.6

18.5

107

419

N06AG02

ATC

moclobemide; oral

2.8

18.4

340

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.2

18.4

158

739

M79.7

ICD-10 Finland

Fibromyalgia

2.5

18.4

116

474

H02AA02

ATC

fludrocortisone; oral

6.4

18.4

A10BH01

ATC

sitagliptin; oral

2.4

18.3

121

505

Z01.2

ICD-10 Finland

Dental examination

1.4

18.3

1607

13421

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.7

18.3

358

G04BD12

ATC

mirabegron; oral

2.3

18.2

146

664

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.4

18.2

121

507

SPAT1254

SPAT

Administration of medicine

1.6

18.1

425

2738

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.3

18.0

205

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

18.0

2353

20975

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

18.0

1093

8574

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

17.9

496

3325

G03FA14

ATC

dydrogesterone and estrogen; systemic

2.4

17.9

124

529

R60.0

ICD-10 Finland

Localized oedema

1.9

17.8

223

1198

TLW20

NOMESCO Finland

Medical ovulation induction

+∞

17.7

G03HB01

ATC

cyproterone and estrogen; oral

1.5

17.7

561

3876

R35

ICD-10 Finland

Polyuria

2.7

17.7

347

G04BD04

ATC

oxybutynin; oral, transdermal

2.7

17.7

353

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.6

17.7

106

423

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.2

17.6

143

653

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

17.6

291

1704

XCK00

NOMESCO Finland

Perimetry

2.4

17.6

127

552

K59.01

ICD-10 Finland

Constipation outlet obstruction type

6.4

17.5

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

17.5

1318

10705

UJD02

NOMESCO Finland

Gastroscopy

2.8

17.4

333

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

17.4

2478

22347

XKC03

NOMESCO Finland

Water cystometry

3.8

17.3

138

N06AA12

ATC

doxepin; systemic

2.7

17.3

363

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.3

17.2

133

595

L28

ICPC

Limited function/disability (L)

1.7

17.2

302

1800

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

17.2

585

4103

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.6

17.2

370

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

17.1

637

4552

R10.2

ICD-10 Finland

Pelvic and perineal pain

3.1

17.1

233

N05AL01

ATC

sulpiride; systemic

4.7

17.0

P99

ICPC

Psychological disorders other

2.3

17.0

135

611

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3.1

17.0

228

WX892

NOMESCO Finland

Monitored bed care

2.2

17.0

150

709

A46

ICD-10 Finland

Erysipelas

1.9

17.0

216

1167

T82

ICPC

Obesity

2.1

16.9

158

764

R00.2

ICD-10 Finland

Palpitations

1.8

16.9

246

1388

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

16.8

568

3976

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

16.7

482

3258

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

16.7

218

1187

SPAT1262

SPAT

Handing over of treatment supplies

1.7

16.7

324

1986

A10AB04

ATC

insulin lispro; parenteral

2.4

16.7

116

496

U07

ICPC

Urine symptom/complaint other

2.1

16.7

168

836

A10BK03

ATC

empagliflozin; oral

2.3

16.6

133

604

A10AB01

ATC

insulin (human); parenteral

2.3

16.5

126

561

M54.3

ICD-10 Finland

Sciatica

2.2

16.4

137

633

E28.8

ICD-10 Finland

Other ovarian dysfunction

23.1

16.4

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

16.4

315

1925

P76

ICPC

Depressive disorder

1.7

16.4

298

1794

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

16.2

1325

10864

R32

ICD-10 Finland

Unspecified urinary incontinence

3.6

16.2

145

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

16.2

840

6387

ZXD05

NOMESCO Finland

Urgent procedure

1.4

16.1

895

6882

SPAT1153

SPAT

Removal of sutures

1.5

16.1

638

4608

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

16.1

274

1618

ZXA00

NOMESCO Finland

Right side

1.6

16.1

450

3018

N05BE01

ATC

buspirone; oral

2.8

16.1

290

N03AF02

ATC

oxcarbazepine; oral

2.5

16.1

100

406

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

16.1

227

1268

Z32.0

ICD-10 Finland

Pregnancy, not (yet) confirmed

2.1

16.1

160

793

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

16.0

209

1138

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

16.0

2450

22159

WX882

NOMESCO Finland

High dependency care

3.2

16.0

195

SDA03

NOMESCO Finland

Periodontal treatment

1.4

15.9

1282

10480

A07AA02

ATC

nystatin; oral

2.4

15.9

113

488

SPAT1240

SPAT

Therapeutic discussion

1.5

15.9

486

3326

XA800

NOMESCO Finland

Neuropsychological investigation

2.4

15.9

111

476

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

4.7

15.9

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

15.8

1676

14291

A10BJ02

ATC

liraglutide; parenteral

3.0

15.8

228

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

15.7

300

1829

N80.4

ICD-10 Finland

Endometriosis of rectovaginal septum and vagina

33.5

15.7

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

15.7

598

4286

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

15.6

269

1594

IER01

NOMESCO Finland

Psychoeducation, group

3.6

15.6

144

R2110

NOMESCO Finland

Giving the first information

1.9

15.5

193

1034

G01AA10

ATC

clindamycin; vaginal

1.5

15.5

486

3343

D12

ICPC

Constipation

2.7

15.5

308

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

15.4

290

1761

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.4

15.4

ZXA05

NOMESCO Finland

Left side

1.6

15.4

414

2751

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

15.4

144

697

S29

ICPC

Skin symptom/complaint other

1.5

15.4

499

3457

D19

ICPC

Teeth/gum symptom/complaint

1.4

15.4

954

7468

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

15.3

207

1140

F60.5

ICD-10 Finland

Anankastic personality disorder

3.3

15.3

180

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.2

15.3

134

632

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.8

15.3

287

S06.0

ICD-10 Finland

Concussion

1.7

15.3

305

1883

D07AC01

ATC

betamethasone; topical

1.4

15.1

907

7054

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.5

15.1

406

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

15.1

1502

12652

F22.0

ICD-10 Finland

Delusional disorder

3.9

15.0

115

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

15.0

176

926

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

14.9

1638

13992

P01

ICPC

Feeling anxious/nervous/tense

1.4

14.8

686

5095

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.7

14.8

292

N02BF01

ATC

gabapentin; oral

1.9

14.8

177

937

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

4.0

14.8

103

H3601, E103,

ICD-10 Finland

4.0

14.8

103

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

3.3

14.8

164

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

14.7

1369

11397

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

4.9

14.7

Q51.0

ICD-10 Finland

Agenesis and aplasia of uterus

25.1

14.7

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

3.2

14.6

180

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.9

14.6

202

1121

62801

ICD-8 Finland

Sterility, female, Sterilitas secundaria

+∞

14.6

N85.6

ICD-10 Finland

Intrauterine synechiae

+∞

14.6

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

14.6

333

2127

N83.5

ICD-10 Finland

Torsion of ovary, ovarian pedicle and fallopian tube

80.5

14.6

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.4

14.6

395

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

14.6

191

1042

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

14.5

892

6958

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.0

14.5

223

L04AA01

ATC

[U] ciclosporin

4.4

14.5

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.8

14.5

256

K03.28

ICD-10 Finland

Other erosion of teeth

2.5

14.5

366

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

14.4

222

1273

N30.0

ICD-10 Finland

Acute cystitis

1.5

14.3

541

3863

N06AX05

ATC

trazodone; oral

2.5

14.3

344

1413

FHL

Laparoscopy and other therapeutic procedure

4.4

14.2

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

4.4

14.2

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

14.2

144

718

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

14.2

301

1886

L04AA06

ATC

mycophenolic acid; systemic

3.3

14.2

158

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.6

14.2

129

A01AB04

ATC

amphotericin B; local oral

2.7

14.2

270

G03FA01

ATC

norethisterone and estrogen; systemic

1.8

14.2

201

1124

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.8

14.2

206

1161

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

14.2

248

F34.1

ICD-10 Finland

Dysthymia

2.1

14.1

131

632

SPAT1301

SPAT

No procedures

1.4

14.1

860

6695

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.1

14.0

131

634

N06AX26

ATC

vortioxetine; oral

1.7

14.0

268

1635

LDB20

NOMESCO Finland

Electrocoagulation or laser therapy of cervix uteri

5.4

14.0

R06AE07

ATC

cetirizine; oral

1.3

14.0

1439

12130

S22.3

ICD-10 Finland

Fracture of rib

2.2

14.0

112

510

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

14.0

176

948

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.0

13.9

163

856

A28

ICPC

Limited function/disability NOS

1.8

13.9

209

1190

ZX120

NOMESCO Finland

Intravenous

1.8

13.9

206

1169

F10.24

ICD-10 Finland

Alcohol depence active use

3.8

13.9

108

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.4

13.8

141

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

3.3

13.8

161

M25.5

ICD-10 Finland

Pain in joint

1.4

13.8

865

6760

L01

ICPC

Neck symptom/complaint

1.5

13.8

469

3277

R05

ICPC

Cough

1.4

13.8

720

5457

SPAT1167

SPAT

Insertion of urinary catheter

4.5

13.8

J01FA06

ATC

roxithromycin; oral

1.4

13.7

979

7807

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.8

13.7

241

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.1

13.7

182

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.6

13.7

298

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

5.3

13.7

LBE01

NOMESCO Finland

Laparoscopic salpingectomy

3.0

13.7

198

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.4

13.7

419

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.0

13.7

193

G03FB01

ATC

norgestrel and estrogen; systemic

4.2

13.7

S22

ICPC

Nail symptom/complaint

1.9

13.6

165

877

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

3.7

13.6

114

127

Kela drug reimbursment

Transplant complication

4.0

13.6

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

13.6

228

1341

A11

ICPC

Chest pain NOS

2.0

13.6

143

724

C10AA01

ATC

simvastatin; oral

1.5

13.6

390

2628

D01AE16

ATC

amorolfine; topical

1.8

13.6

206

1177

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

13.5

467

3272

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.2

13.5

163

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

13.5

209

1200

R4120

NOMESCO Finland

Occupational therapy

1.9

13.5

162

858

N02BF02

ATC

pregabalin; oral

2.0

13.5

140

705

A06AC51

ATC

ispaghula, combinations; oral

2.3

13.5

103

460

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

3.0

13.5

200

R96

ICPC

Asthma

1.7

13.5

243

1459

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.3

13.4

102

454

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

4.2

13.4

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.2

13.4

E30.09

ICD-10 Finland

Delayed puberty NOS

18.3

13.4

IGY02, ,

SPAT

3.1

13.3

180

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

13.3

1053

8524

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

13.3

448

3123

C10AA07

ATC

rosuvastatin; oral

1.5

13.3

426

2939

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

2.9

13.2

213

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.2

13.2

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

13.2

1079

8776

XF402

NOMESCO Finland

ECG with work load test

2.1

13.2

126

616

Q52.0

ICD-10 Finland

Congenital absence of vagina

40.2

13.1

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.4

13.1

573

4202

102

Kela drug reimbursment

Diabetes insipidus

15.1

13.1

IHZ07, ,

SPAT

4.8

13.1

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.4

13.0

132

N06AA04

ATC

clomipramine; systemic

3.7

13.0

113

R03AC02

ATC

salbutamol; inhalant

1.3

13.0

1648

14251

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

13.0

305

1960

E87.6

ICD-10 Finland

Hypokalaemia

2.8

13.0

243

J01AA02

ATC

doxycycline; systemic

1.3

12.9

1972

17486

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

12.9

112

527

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.4

12.9

774

5995

C10AA05

ATC

atorvastatin; oral

1.5

12.9

461

3252

M03BX02

ATC

tizanidine; oral

1.3

12.9

1689

14665

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.5

12.9

338

SPAT1216

SPAT

Assessment of functional ability

1.7

12.8

254

1563

N89.6

ICD-10 Finland

Tight hymenal ring

50.2

12.8

XKD06

NOMESCO Finland

Physiologic investigation of micturition

3.6

12.8

119

P98

ICPC

Psychosis NOS/other

3.7

12.8

105

N06AB08

ATC

fluvoxamine; oral

2.9

12.8

206

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

12.8

445

IEY02

NOMESCO Finland

Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)

5.4

12.8

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

12.8

433

3022

SPAT1255

SPAT

Intravenous administration of medicine

2.1

12.8

128

637

J01DA01

ATC

[U] cefalexin

1.3

12.8

1710

14885

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

12.8

940

7519

SFA10

NOMESCO Finland

One-surface restoration

1.3

12.7

1821

15988

R5599

NOMESCO Finland

Other rehabilitation service

2.6

12.7

280

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.2

12.7

110

517

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

5.8

12.7

L13

ICPC

Hip symptom/complaint

1.6

12.7

332

2188

S10

ICPC

Boil/carbuncle

1.9

12.7

151

798

P03

ICPC

Feeling depressed

1.5

12.7

479

3416

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.6

12.7

275

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

12.6

182

1023

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.7

12.6

261

1625

Z00.0

ICD-10 Finland

General medical examination

1.5

12.6

518

3753

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

12.6

134

681

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

6.0

12.6

G04BD07

ATC

tolterodine; oral

2.9

12.6

192

A29

ICPC

General symptom/complaint other

1.6

12.5

274

1732

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.9

12.5

209

C10AB05

ATC

fenofibrate; oral

5.2

12.5

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

3.4

12.5

131

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

12.4

200

1162

E23.2

ICD-10 Finland

Diabetes insipidus

13.2

12.4

N96

ICD-10 Finland

Habitual aborter

13.2

12.4

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

4.9

12.4

N05BA09

ATC

clobazam; oral

4.4

12.4

SFA20

NOMESCO Finland

Two-surface restoration

1.3

12.4

1869

16504

188

Kela drug reimbursment

Psychosis requiring demanding treatment

3.6

12.3

108

J05AB01

ATC

aciclovir; systemic

1.4

12.3

586

4362

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.6

12.3

310

2028

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.1

12.2

163

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

12.2

194

1123

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.5

12.2

118

L05

ICPC

Flank/axilla symptom/complaint

1.9

12.2

145

766

K62.3

ICD-10 Finland

Rectal prolapse

5.1

12.2

E66

ICD-10 Finland

Obesity

1.8

12.2

179

1013

H53.4

ICD-10 Finland

Visual field defects

3.3

12.2

133

R00.1

ICD-10 Finland

Bradycardia, unspecified

3.2

12.2

143

F60.8

ICD-10 Finland

Other specific personality disorders

3.8

12.2

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

4.9

12.1

P73

ICPC

Affective psychosis

4.9

12.1

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.1

12.1

110

527

K04.0

ICD-10 Finland

Pulpitis

1.6

12.1

329

2187

E03

ICD-10 Finland

Other hypothyroidism

1.8

12.1

178

1007

ICB03, ,

SPAT

5.5

12.1

N93.0

ICD-10 Finland

Postcoital and contact bleeding

4.1

12.1

Z31.6

ICD-10 Finland

General counselling and advice on procreation

3.2

12.0

149

H43.1

ICD-10 Finland

Vitreous haemorrhage

3.2

12.0

144

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

12.0

164

907

A08

ICPC

Swelling

2.2

12.0

431

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

12.0

660

5033

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.0

12.0

122

611

IBB01

NOMESCO Finland

Psychiatric functioning capacity evaluation

5.0

11.9

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.7

11.9

101

L15

ICPC

Knee symptom/complaint

1.4

11.9

575

4287

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

11.9

1156

9601

SFA30

NOMESCO Finland

Three-surface restoration

1.3

11.9

1033

8446

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.9

11.9

157

859

TAB00

NOMESCO Finland

Lumbar puncture

2.0

11.9

130

668

SPAT1139

SPAT

Nutrition survey

2.3

11.9

401

H04AA01

ATC

glucagon; nasal, parenteral

2.1

11.9

106

505

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

11.9

118

586

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

11.8

339

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.0

11.8

133

690

M01AE02

ATC

naproxen; oral, rectal

1.3

11.8

1730

15170

A41.9

ICD-10 Finland

Sepsis, unspecified

2.7

11.8

221

Z70.8

ICD-10 Finland

Other sex counselling

5.4

11.8

SPAT1260

SPAT

Consultation of another employee

1.5

11.8

465

3340

H01CC02

ATC

cetrorelix; parenteral

11.7

11.8

H01

ICPC

Ear pain/earache

1.5

11.8

438

3110

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

11.8

285

1844

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

11.7

153

834

M01AH02

ATC

rofecoxib; oral

1.8

11.7

175

995

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

11.7

692

5336

M05BA07

ATC

risedronic acid; oral

3.1

11.7

157

H02AB04

ATC

methylprednisolone; systemic

1.6

11.6

304

2003

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

5.5

11.6

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.2

11.6

137

Q50.10

ICD-10 Finland

A developmental cyst in the ovary

3.3

11.6

132

C07AB02

ATC

metoprolol; systemic

1.6

11.6

268

1715

A10AA02, ,

ATC

2.3

11.6

405

ZXA10

NOMESCO Finland

Bilateral

1.5

11.6

356

2431

N90.6

ICD-10 Finland

Hypertrophy of vulva

65.2

11.6

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.8

11.6

212

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

11.6

261

1661

R30.0

ICD-10 Finland

Dysuria

2.0

11.6

116

578

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

11.5

125

640

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.6

11.5

241

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

3.3

11.5

133

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.5

11.5

295

L12

ICPC

Hand/finger symptom/complaint

1.4

11.5

462

3332

L08

ICPC

Shoulder symptom/complaint

1.5

11.5

438

3127

LCA30

NOMESCO Finland

Transfer of oocyte or embryo to uterus in assisted fertilisation

+∞

11.5

N90.1

ICD-10 Finland

Moderate vulvar dysplasia

+∞

11.5

N95.9

ICD-10 Finland

Menopausal and perimenopausal disorder, unspecified

+∞

11.5

B01AA03

ATC

warfarin; systemic

1.8

11.4

169

958

J01FA10

ATC

azithromycin; systemic

1.3

11.4

1927

17176

A04

ICPC

Weakness/tiredness general

1.4

11.4

462

3335

NF1AA

NOMESCO Finland

Hip X-ray examination

2.1

11.4

111

547

G04BD08

ATC

solifenacin; oral

2.4

11.4

345

F32.1

ICD-10 Finland

Moderate depressive episode

1.6

11.3

257

1638

L14

ICPC

Leg/thigh symptom/complaint

1.8

11.3

182

1058

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

11.3

109

535

J01CA04

ATC

amoxicillin; systemic

1.4

11.3

2749

25782

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

11.3

1123

9342

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

11.3

118

597

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.8

11.3

193

N80.89

ICD-10 Finland

Endometriosis with other specified or multiple localization

35.1

11.3

104

Kela drug reimbursment

Thyroid insufficiency

1.8

11.2

163

919

A05

ICPC

Feeling ill

1.6

11.2

285

1866

B82

ICPC

Anaemia other/unspecified

2.7

11.2

216

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

11.2

284

1859

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.7

11.2

C10AX09

ATC

ezetimibe; oral

1.8

11.1

158

885

J01MA06

ATC

norfloxacin; oral

1.6

11.1

272

1765

N99.3

ICD-10 Finland

Prolapse of vaginal vault after hysterectomy

20.1

11.1

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.9

11.1

178

R03BB04

ATC

tiotropium bromide; inhalant

1.9

11.1

130

684

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

11.1

159

893

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.8

11.1

161

908

N70.0

ICD-10 Finland

Acute salpingitis and oophoritis

3.9

11.1

G03DC03

ATC

lynestrenol; oral

2.6

11.1

252

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

11.1

995

8158

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

11.1

176

1020

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.2

11.1

394

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

3.0

11.1

157

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

11.1

124

643

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

11.1

375

G01AF04

ATC

miconazole; vaginal

2.0

11.0

125

651

N89.8

ICD-10 Finland

Other specified noninflammatory disorders of vagina

5.7

11.0

WZC00, ,

SPAT

1.5

11.0

329

2235

X58

ICD-10 Finland

Exposure to other specified factors

1.5

11.0

367

2551

S21

ICPC

Skin texture symptom/complaint

1.5

11.0

348

2393

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.2

11.0

137

183

Kela drug reimbursment

Lamotrigin and topiramate

3.2

10.9

132

U02

ICPC

Urinary frequency/urgency

1.5

10.9

401

2839

D06

ICPC

Abdominal pain localized other

1.6

10.9

268

1740

IHZ04, ,

SPAT

2.8

10.9

202

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.1

10.9

475

N06AA10

ATC

nortriptyline; systemic

2.8

10.9

191

SPAT1229

SPAT

Assessment of need for aid

2.0

10.9

112

564

M89.0

ICD-10 Finland

Algoneurodystrophy

3.7

10.8

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

10.8

251

1609

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

2.9

10.8

170

N07BB01

ATC

disulfiram; oral

2.3

10.8

354

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.8

10.7

163

932

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.5

10.7

268

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.6

10.7

270

1764

LFE10

NOMESCO Finland

Plastic repair of vulva

28.1

10.7

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.1

10.7

105

519

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

10.7

473

3467

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

10.6

337

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.6

10.6

272

1785

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

10.6

540

4060

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

1.8

10.6

144

797

WVA20, ,

SPAT

2.4

10.5

283

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.7

10.5

195

K03.2

ICD-10 Finland

Erosion of teeth

2.4

10.5

277

A10AA01, ,

ATC

2.2

10.5

390

B01AB04

ATC

dalteparin; parenteral

2.0

10.5

114

585

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

9.2

10.5

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.0

10.5

118

613

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.2

10.5

423

XF404

NOMESCO Finland

Ambulatory ECG

1.9

10.5

139

763

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.6

10.5

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

10.4

278

1840

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

10.4

579

4412

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.8

10.4

179

N06AA06

ATC

trimipramine; systemic

2.8

10.4

179

E000001, ,

ATC

1.4

10.4

623

4804

LCG31

NOMESCO Finland

Laparoscopic resection or transcision of sacrouterine ligaments

110.4

10.4

6170A

ICD-9 Finland

Endometriosis of uterus

+∞

10.4

62650

ICD-8 Finland

Disorders of menstruation, Irregular

+∞

10.4

62611

ICD-8 Finland

Disorders of menstruation, Oligomenorrhoea

+∞

10.4

N97.2

ICD-10 Finland

Female infertility of uterine origin

+∞

10.4

P06

ICPC

Sleep disturbance

1.5

10.4

348

2418

J46

ICD-10 Finland

Status asthmaticus

2.3

10.4

315

R03DC03

ATC

montelukast; oral

1.4

10.4

464

3406

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.4

10.4

452

3303

A03FA02

ATC

cisapride; oral, rectal

2.0

10.4

118

615

A10BK01

ATC

dapagliflozin; oral

2.1

10.4

438

S06

ICPC

Rash localized

1.8

10.4

147

824

R15

ICD-10 Finland

Faecal incontinence

3.1

10.3

142

Z31.3

ICD-10 Finland

Other assisted fertilization methods

16.1

10.3

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.1

10.3

472

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.1

10.3

472

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.1

10.3

137

N06AX22

ATC

agomelatine; oral

2.2

10.3

380

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.5

10.3

R05

ICD-10 Finland

Cough

1.4

10.3

529

3980

SPAT1310

SPAT

Counselling related to known health issue

1.3

10.3

932

7637

3071A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Anorexia nervosa

10.6

10.3

X07

ICPC

Menstruation irregular/frequent

2.1

10.3

440

C05AA08

ATC

fluocortolone; rectal, topical

1.6

10.2

227

1439

LFA10

NOMESCO Finland

Incision of imperforate hymen or remnant of hymen

23.4

10.2

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.8

10.2

181

Z31.5

ICD-10 Finland

Genetic counselling

1.7

10.2

207

1283

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

1.9

10.2

118

619

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

10.2

256

1672

N70.1

ICD-10 Finland

Chronic salpingitis and oophoritis

7.5

10.2

Y0609

ICD-8 Finland

Examination of the urinary and genital organs, Genital organs

4.1

10.1

301

Kela drug reimbursment

Growth hormone

13.1

10.1

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.8

10.1

182

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.4

10.1

108

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

10.1

101

503

M48.0

ICD-10 Finland

Spinal stenosis

1.9

10.1

119

628

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.8

10.1

177

J20

ICD-10 Finland

Acute bronchitis

1.6

10.1

254

1661

SFA00

NOMESCO Finland

Small restoration

1.5

10.0

369

2613

R4110, ,

SPAT

1.7

10.0

166

974

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.9

10.0

120

637

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

10.0

265

1751

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

10.0

161

937

J01FA01

ATC

erythromycin; systemic

1.4

10.0

491

3664

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.6

10.0

206

L86

ICPC

Back syndrome with radiating pain

1.9

10.0

129

702

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.9

10.0

120

638

N83.8

ICD-10 Finland

Other noninflammatory disorders of ovary, fallopian tube and broad ligament

40.2

10.0

SPAT1104

SPAT

Monitoring of emergency patient

1.9

9.9

120

639

R03BA05

ATC

fluticasone; inhalant

1.4

9.9

510

3835

D01AE15

ATC

terbinafine; topical

1.9

9.9

114

597

D07XC01

ATC

betamethasone; topical

1.6

9.9

225

1436

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

3.7

9.9

F28

ICD-10 Finland

Other nonorganic psychotic disorders

4.3

9.8

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.3

9.8

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

9.8

262

1735

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

9.8

441

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.4

9.8

570

4372

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

9.8

448

M04AA01

ATC

allopurinol; systemic

2.1

9.8

448

A10BX07

ATC

[U] liraglutide

4.4

9.8

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.6

9.8

220

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.9

9.8

SPAT1263

SPAT

Sampling

1.3

9.8

1282

10995

N73.6

ICD-10 Finland

Female pelvic peritoneal adhesions

10.6

9.8

J96.1

ICD-10 Finland

Chronic respiratory failure

4.0

9.8

ZXY49

NOMESCO Finland

Other health care provider

3.8

9.8

T78.4

ICD-10 Finland

Allergy, unspecified

1.7

9.8

163

959

JG1JB

NOMESCO Finland

Defekography with X-ray

9.5

9.7

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

1.9

9.7

113

594

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

9.7

120

644

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.8

9.7

140

789

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.3

9.7

106

C08CA01

ATC

amlodipine; oral

1.4

9.7

437

3212

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.9

9.7

124

673

R13

ICD-10 Finland

Dysphagia

2.0

9.7

104

532

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

9.7

491

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

3.9

9.7

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.6

9.6

L04AX01

ATC

azathioprine; systemic

1.9

9.6

112

589

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

9.6

107

554

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

4.2

9.6

K92.0

ICD-10 Finland

Haematemesis

3.1

9.6

127

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

2.5

9.6

240

R52.1

ICD-10 Finland

Chronic intractable pain

3.9

9.6

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.8

9.6

136

763

S04

ICPC

Lump/swelling localized

1.5

9.6

303

2082

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

9.6

358

2543

R03BA01

ATC

beclometasone; inhalant

1.5

9.5

316

2191

SPAT1097

SPAT

Recording of ECG

1.6

9.5

211

1337

X57

ICD-10 Finland

Unspecified privation

2.6

9.5

217

WX213

NOMESCO Finland

Lower leg blockade

4.8

9.5

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.4

9.5

253

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

4.6

9.5

KMAK, ,

NOMESCO Finland

1.3

9.5

1688

14985

N94.9

ICD-10 Finland

Unspecified condition associated with female genital organs and menstrual cycle

9.1

9.5

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

9.1

9.5

W11

ICPC

Contraception oral

0.7

9.5

506

6565

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.0

9.5

502

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

3.5

9.5

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.2

9.5

118

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

9.4

670

5295

M02AA07

ATC

piroxicam; topical

1.3

9.4

624

4880

RF220, ,

NOMESCO Finland

3.3

9.4

108

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.1

9.4

N80.5

ICD-10 Finland

Endometriosis of intestine

100.3

9.4

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

7.5

9.4

SPAT1312

SPAT

General health counselling

1.3

9.4

1070

9008

M01AB05

ATC

diclofenac; systemic, rectal

1.3

9.4

1633

14455

EB1VA, ,

NOMESCO Finland

1.5

9.4

314

2182

N89.0

ICD-10 Finland

Mild vaginal dysplasia

+∞

9.4

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.2

9.4

343

SGA01

NOMESCO Finland

Emergency treatment

1.4

9.4

507

3844

SPAT1252

SPAT

Overall medication plan or its review

2.0

9.4

463

SPAT1281

SPAT

Other administrative function

1.6

9.3

209

1328

E23.03

ICD-10 Finland

Lack of ACTH

12.4

9.3

78400

ICD-8 Finland

Symptoms referable to upper gastro-intestinal tract, Anorexia

21.7

9.3

LFB20

NOMESCO Finland

Destruction of lesion of vulva or perineum

4.4

9.3

D27.91

ICD-10 Finland

Benign epithelial tumor of the ovary (ovary)

4.0

9.3

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

9.3

290

1986

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

9.3

176

1072

IEZ99

NOMESCO Finland

Other psychiatric rehabilitation intervention

4.5

9.3

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

4.5

9.3

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

9.3

199

1251

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.7

9.3

185

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.0

9.3

130

M02AA10

ATC

ketoprofen; topical

1.5

9.2

282

1923

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.4

9.2

372

2679

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

446

339

15.06

307.65

1.3

4.40

3.54

ug/l

1.29

398

303

(3009214) Lutropin [Units/volume] in Serum or Plasma

820

626

17.11

307.65

1.8

1.4

8.25

11.01

u/l

4.16

654

502

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

561

424

15.74

307.65

2.0

1.4

0.22

0.35

nmol/l

3.09

453

320

(3023323) Follitropin [Units/volume] in Serum or Plasma

807

1672

6.07

307.65

1.8

1.3

12.36

21.62

iu/l

17.35

660

1451

(3017446) Testosterone [Moles/volume] in Serum or Plasma

359

342

11.66

307.65

1.4

1.36

2.01

nmol/l

2.05

312

281

(3021387) Prolactin [Units/volume] in Serum or Plasma

828

1449

7.30

307.65

2.2

1.6

313.98

391.43

mu/l

2.24

770

1252

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

235

167

15.08

260.63

1.3

5.96

5.89

umol/l

0.06

218

152

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

307

364

9.20

242.08

2.1

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

298

484

6.67

177.59

1.8

1.3

12.55

26.43

u/l

11.71

275

385

(3036481) Cortisol [Moles/volume] in Serum or Plasma

601

2177

3.15

125.49

2.8

2.1

384.17

391.61

nmol/l

0.33

558

2002

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

21.72

124.83

1.5

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

554

2045

3.05

111.05

6.9

5.0

1.09

1.06

mmol/l

2.20

520

1916

(43055514) Macroprolactin [Presence] in Serum or Plasma

107

12.98

110.54

1.5

1.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1346

7841

2.21

101.20

5.4

4.2

36.85

36.73

g/l

0.34

1259

7287

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

13.56

100.87

1.2

1.3

20.00

16.78

pmol/l

0.95

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1480

9002

2.17

99.22

8.2

5.2

1.21

1.22

mmol/l

0.89

1262

7645

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2777

21871

2.72

97.06

5.9

4.0

14.16

14.32

pmol/l

3.41

2643

20214

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1574

10005

2.10

91.87

2.9

2.2

74.56

72.42

nmol/l

2.46

1478

9378

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1336

8062

2.11

88.78

7.4

4.6

1.21

1.22

mmol/l

0.83

1238

7436

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2996

25049

3.16

83.75

6.9

4.5

1.69

1.88

mu/l

1.54

2893

23660

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2228

16429

2.10

83.34

8.1

6.2

72.83

72.75

u/l

0.03

2124

15456

(3001556) Androgen free Index in Serum or Plasma

29.91

79.99

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1126

6577

2.08

79.70

2.8

3.1

2.34

2.35

mmol/l

0.69

1028

5955

(3013826) Glucose [Moles/volume] in Serum or Plasma

1782

12267

1.99

79.05

5.9

3.7

6.38

6.23

mmol/l

1.96

1614

10641

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1054

6036

2.10

78.43

3.3

2.3

54.35

57.68

u/l

1.28

987

5538

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

409

1539

2.89

77.70

3.6

2.4

0.22

g/l

0.00

377

1448

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1233

7518

2.02

76.94

2.1

1.7

100.79

97.68

pmol/l

1.29

632

4050

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1515

9950

1.97

76.12

6.2

5.1

9.27

9.94

umol/l

1.59

1431

9288

(3019309) Folate [Moles/volume] in Red Blood Cells

593

2718

2.44

75.58

1.8

1.6

1235.13

1164.66

nmol/l

1.05

495

2090

(3023103) Potassium [Moles/volume] in Serum or Plasma

2922

24507

2.70

73.49

16.2

8.6

3.91

3.88

mmol/l

3.64

2867

23587

(3019550) Sodium [Moles/volume] in Serum or Plasma

2917

24450

2.68

73.36

16.1

8.5

139.29

139.45

mmol/l

3.50

2868

23614

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1186

7230

2.00

73.23

1.5

1.3

2.06

1.84

u/ml

0.17

346

2017

(3018418) pH of Serum or Plasma

955

5387

2.09

73.09

4.5

3.3

7.40

0.17

188

999

(40760892) CBC W Ordered Manual Differential panel - Blood

1659

11364

1.93

72.28

7.7

6.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1942

14020

1.94

72.10

12.1

8.3

3.88

3.98

e9/l

1.20

1734

12326

(3012095) Magnesium [Moles/volume] in Serum or Plasma

575

2653

2.41

71.93

4.4

3.2

0.81

0.83

mmol/l

2.14

539

2493

(3006315) Basophils [#/volume] in Blood

1733

12092

1.91

70.87

7.5

5.7

0.04

e9/l

0.74

1558

10687

(3001604) Monocytes [#/volume] in Blood

1729

12071

1.91

70.42

7.5

5.7

0.51

0.53

e9/l

2.91

1556

10693

(3019198) Lymphocytes [#/volume] in Blood

1793

12722

1.90

68.88

7.5

5.6

1.92

2.00

e9/l

3.85

1649

11506

(3005082) Progesterone [Moles/volume] in Serum or Plasma

141

7.21

66.14

1.4

1.3

28.58

22.67

nmol/l

0.74

125

(3013115) Eosinophils [#/volume] in Blood

1769

12606

1.87

65.90

8.1

5.9

0.16

0.18

e9/l

2.87

1609

11279

(3006504) Eosinophils/100 leukocytes in Blood

1624

11441

1.83

61.03

7.4

5.7

2.50

2.71

3.75

1540

10793

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1968

14710

1.84

60.76

3.6

2.7

66.19

61.23

ug/l

0.96

1875

13949

(3021960) Folate [Moles/volume] in Serum or Plasma

725

3928

2.08

60.21

1.7

1.4

21.80

20.52

nmol/l

1.65

659

3497

(3019069) Monocytes/100 leukocytes in Blood

1626

11508

1.82

59.73

7.7

5.9

7.87

7.83

0.21

1547

10875

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

935

5614

1.93

57.63

2.6

2.1

2.72

2.62

mg/l

0.79

830

4835

(3022096) Basophils/100 leukocytes in Blood

1561

10992

1.80

57.61

7.5

5.8

0.68

0.66

0.49

1473

10314

(3002030) Lymphocytes/100 leukocytes in Blood

1684

12175

1.78

56.38

7.4

5.6

30.10

29.99

0.19

1606

11554

(3018010) Neutrophils/100 leukocytes in Blood

1665

12005

1.78

56.20

7.2

5.5

56.23

56.37

0.21

1587

11381

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

816

4731

1.96

55.47

2.6

2.0

152.14

162.62

u/l

0.18

773

4465

(3013707) Erythrocyte sedimentation rate by Westergren method

2247

17751

1.84

55.12

4.3

3.4

10.49

9.79

mm/h

2.07

2115

16604

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

595

3125

2.10

53.00

2.5

2.0

5068.42

7554.26

u/l

1.24

218

1186

(3031040) Bacteria [#/volume] in Urine by Automated count

2203

17417

1.80

52.51

5.0

3.5

2428.55

2026.03

e6/l

0.09

163

(3022217) INR in Platelet poor plasma by Coagulation assay

1078

6959

1.82

51.82

9.0

7.1

1.08

1.09

inr

0.17

374

2309

(3037467) Urinalysis macro (dipstick) panel - Urine

2254

17981

1.80

51.66

4.9

3.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

973

6100

1.84

51.39

1.6

1.4

1.99

2.06

g/l

0.77

586

3878

(3021879) Hepatitis B virus core Ab [Presence] in Serum

457

2208

2.24

50.11

1.5

1.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

9.24

49.58

2.0

1.9

0.16

0.19

nmol/l

0.46

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2415

19796

1.82

49.02

5.4

3.8

38.67

37.10

mmol/mol

10.53

2292

18688

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

232

829

2.93

47.79

1.4

1.3

—

(3023368) Bacteria identified in Blood by Culture

706

4074

1.93

47.75

4.7

3.6

—

(40768804) Tissue Pathology biopsy report

1246

8621

1.72

45.69

2.1

1.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1156

7854

1.73

45.17

3.9

2.8

31.70

28.08

u/l

1.51

1106

7534

(3035637) Corticotropin [Mass/volume] in Plasma

120

290

4.26

45.08

2.1

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

855

5337

1.81

44.76

4.3

3.1

7.26

7.58

mmol/l

1.00

769

4753

(3018095) Leukocytes [#/volume] in Urine

1134

7737

1.71

43.19

3.9

3.0

70.96

85.17

e6/l

0.33

737

4703

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

813

5056

1.81

42.81

2.1

1.7

0.85

1.02

mg/l

1.31

626

3652

(3017143) Hepatitis C virus Ab [Presence] in Serum

687

4065

1.87

42.46

1.7

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

685

4055

1.87

42.25

4.8

4.0

12.81

12.01

mg/mmol

0.13

442

2616

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

882

5659

1.76

41.57

3.2

2.5

24.25

25.58

ng/l

0.11

411

2341

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2660

22853

1.85

41.47

12.1

7.6

95.97

95.27

ml/min/173m2

0.84

2189

17928

(3015736) pH of Urine

1398

10163

1.65

41.30

3.6

2.8

5.97

6.01

0.19

116

972

(40758558) Short blood count panel - Blood

902

5848

1.75

40.87

8.5

6.5

—

(3044889) 12 lead EKG panel

1789

13862

1.64

40.74

3.5

2.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

522

2859

1.98

40.53

2.5

2.7

591.55

914.49

ng/l

2.25

416

2313

(3009261) Glucose [Presence] in Urine by Test strip

1667

12720

1.63

40.17

4.0

3.0

0.02

0.00

estimate

0.64

309

2530

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

495

2672

2.00

40.03

2.1

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

1658

12654

1.62

39.76

4.0

3.0

0.00

estimate

0.00

328

2631

(3021447) Carbon dioxide [Partial pressure] in Venous blood

302

1346

2.37

39.65

7.0

3.6

5.99

5.80

kpa

2.21

292

1296

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

403

2024

2.13

39.60

3.1

3.4

4.25

4.64

pmol/l

11.89

365

1818

(3022948) Iron [Moles/volume] in Serum or Plasma

520

2866

1.97

39.58

2.7

2.1

13.84

14.35

umol/l

0.80

491

2687

(3030313) Adrenal Ab [Titer] in Serum

11.90

39.44

1.1

1.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

479

2570

2.01

39.36

2.6

2.2

2.48

2.50

g/l

0.23

441

2376

(3009466) Valproate [Moles/volume] in Serum or Plasma

110

276

4.09

39.32

5.6

5.4

375.55

382.45

umol/l

0.17

237

(3021601) Nitrite [Presence] in Urine by Test strip

1654

12638

1.62

39.31

5.3

4.1

0.00

estimate

0.50

322

2562

(3009343) pH of Capillary blood

226

884

2.67

39.13

3.8

3.2

7.41

7.42

0.12

115

(3026008) Bacteria identified in Urine by Culture

1077

7399

1.68

39.10

3.0

2.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2661

22996

1.82

38.95

4.4

3.0

5.68

5.53

mmol/l

5.19

2516

21512

(36304419) Bacteria [Presence] in Urine

840

5402

1.74

38.85

3.3

2.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

227

895

2.65

38.68

3.8

3.2

5.19

5.09

kpa

1.07

220

853

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3050

27655

2.38

38.52

11.1

7.4

24.64

23.02

u/l

5.02

2967

26753

(3042936) Bacteria identified in Isolate by Culture

474

2554

2.00

38.42

2.1

1.8

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

221

863

2.67

38.38

1.7

4.4

83.48

42.71

u/ml

0.31

213

830

(3030467) Casts [#/volume] in Urine by Automated count

835

5384

1.74

38.16

3.4

2.5

0.29

0.34

e6/l

0.44

609

3850

(3002582) Erythrocytes [#/volume] in Urine

895

5899

1.71

37.70

3.5

2.6

36.38

67.86

e6/l

1.00

673

4248

(3007853) Bacteria identified in Skin by Aerobe culture

463

2500

1.99

37.23

2.1

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

432

2276

2.03

37.22

2.7

2.3

22.18

23.62

1.31

376

1963

(3012516) Albumin [Mass/volume] in Urine

645

3884

1.82

37.13

4.0

3.4

192.38

412.33

mg/l

0.87

422

2474

(3002032) Base excess in Venous blood by calculation

294

1333

2.32

37.05

7.2

3.6

1.80

1.65

mmol/l

0.29

256

1094

(3014111) Lactate [Moles/volume] in Serum or Plasma

279

1242

2.36

36.66

9.7

6.1

1.34

1.30

mmol/l

0.20

270

1211

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

217

859

2.63

36.65

3.7

3.2

1.42

1.44

mmol/l

0.02

154

575

(3024354) Oxygen [Partial pressure] in Venous blood

258

1112

2.43

36.44

6.7

3.2

4.62

4.68

kpa

0.17

246

1068

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2955

26691

2.04

33.95

15.0

8.8

18.95

19.33

mg/l

0.28

2320

19941

(3033658) Prothrombin time (PT) actual/Normal

769

4987

1.71

33.82

5.2

3.3

96.03

97.26

0.74

743

4829

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

432

2352

1.96

33.73

2.0

1.7

—

(3026782) Osmolality of Urine

617

3774

1.78

33.34

3.3

2.4

532.40

535.84

mosm/kgh2o

0.11

531

3176

(3005719) IgG [Mass/volume] in Serum or Plasma

344

1733

2.10

33.29

3.5

2.5

10.11

10.57

g/l

1.72

316

1588

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

535

3139

1.84

33.18

2.5

2.42

mmol/l

0.11

462

2749

(3021589) Normoblasts [#/volume] in Blood

1475

11285

1.56

32.61

10.8

7.4

0.00

e9/l

1.38

1232

9271

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

627

3882

1.76

32.40

1.7

1.5

35315760.12

28081593.95

pmol/l

0.13

555

3351

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

479

2739

1.88

32.16

1.3

1.2

129.13

156.82

iu/ml

0.74

162

1116

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

158

570

2.86

31.89

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

129

415

3.19

31.81

1.4

1.3

296.86

297.81

ug/g

0.01

197

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

524

3107

1.82

31.25

2.9

2.2

1.18

e6/l

0.00

300

1647

(3013512) EKG study

689

4427

1.70

31.02

3.3

2.6

—

(3048689) Calprotectin [Mass/mass] in Stool

610

3799

1.74

30.71

2.1

2.5

88.19

103.84

ug/g

0.69

471

2949

(3000850) Epithelial cells [#/volume] in Urine

631

3973

1.73

30.54

2.9

2.2

10.23

9.86

e6/l

0.18

549

3461

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

250

1148

2.27

30.46

1.9

1.6

—

(3000494) Fungus identified in Specimen by Culture

430

2415

1.90

30.42

1.5

1.4

—

(3000991) Gas panel - Venous blood

263

1235

2.23

30.36

11.1

7.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

335

1736

2.03

29.93

1.9

1.6

—

(3044640) Blood type and Crossmatch panel - Blood

1028

7354

1.58

29.91

2.4

1.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

833

5685

1.62

29.46

4.0

3.0

—

(3016502) Oxygen saturation in Arterial blood

253

1185

2.23

29.37

9.5

7.6

96.35

96.50

0.14

245

1145

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2136

17945

1.54

29.35

3.7

2.5

37.98

30.71

u/l

3.71

2042

17107

(3020779) Urea [Moles/volume] in Serum or Plasma

256

1206

2.22

29.30

9.0

6.7

7.00

7.08

mmol/l

0.08

243

1161

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

337

1768

2.01

29.07

1.9

1.6

—

(40768797) Stomach Pathology biopsy report

415

2353

1.87

28.41

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

428

2452

1.86

28.36

2.9

2.2

29.58

29.14

0.77

413

2362

(3037522) Nuclear Ab [Titer] in Serum

581

3645

1.72

28.27

1.6

1.4

588.24

665.50

titre

0.30

102

745

(3027945) Reticulocytes/100 erythrocytes in Blood

302

1541

2.06

28.10

3.2

2.8

1.76

1.71

0.35

276

1385

(3025130) Human papilloma virus identified in Specimen

114

371

3.15

27.60

1.9

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

281

1413

2.08

27.18

8.9

6.9

5.07

4.97

kpa

1.02

271

1349

(3027801) Oxygen [Partial pressure] in Arterial blood

281

1413

2.08

27.18

8.9

6.9

13.44

13.69

kpa

0.27

269

1349

(3023511) Choriogonadotropin [Units/volume] in Urine

339

1824

1.96

27.14

1.5

1.3

—

(3003396) Base excess in Arterial blood by calculation

280

1408

2.08

27.08

8.9

7.0

0.57

0.75

mmol/l

0.28

230

1075

(3028026) IgM [Mass/volume] in Serum or Plasma

264

1322

2.08

25.79

2.1

1.8

1.39

1.40

g/l

0.04

243

1225

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

482

2946

1.75

25.55

3.0

2.3

6.60

5.33

e6/l

1.03

262

1489

(40765089) Chromosome analysis panel - Blood by G-banded

5.51

25.53

1.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

234

1123

2.17

25.53

10.2

7.9

119.81

119.99

g/l

0.05

228

1095

(3026493) Urate [Moles/volume] in Serum or Plasma

660

4389

1.63

25.43

2.4

2.1

4007.23

2842.80

umol/l

0.31

592

3993

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1535

12274

1.47

25.07

2.8

2.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

780

5424

1.57

24.85

2.3

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

462

2823

1.74

24.45

3.5

2.7

546.13

460.64

ng/l

0.08

240

1463

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

336

1865

1.89

24.42

2.8

2.1

29.70

35.33

u/l

2.02

278

1603

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

155

635

2.51

24.36

2.4

1.9

1.21

1.35

g/l

1.02

126

566

(40761511) CBC panel - Blood by Automated count

3091

28901

2.12

24.34

14.5

8.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

380

2201

1.82

24.12

3.7

2.4

5.73

6.94

umol/l

1.04

309

1831

(3023183) Ammonium ion [Moles/volume] in Plasma

276

3.32

24.04

3.0

2.7

31.68

32.64

umol/l

0.17

251

(36660697) Celiac disease serology panel - Serum

429

2586

1.76

23.77

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

184

833

2.28

23.14

1.7

1.5

—

(3003181) Sodium [Moles/volume] in Urine

182

3.85

23.10

2.4

1.5

70.60

65.14

mmol/l

0.29

145

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

177

795

2.30

22.68

2.0

2.5

5.01

5.68

ug/l

0.29

153

692

(3022313) Gas panel - Capillary blood

147

608

2.48

22.65

4.3

3.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

548

3577

1.64

22.49

2.2

1.6

1.42

1.33

3.31

492

3238

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

230

1154

2.07

22.32

3.8

3.6

80.08

72.62

ng/l

0.64

207

1040

(3023520) Reticulocytes [#/volume] in Blood

217

1067

2.11

22.21

3.1

2.5

72.49

70.69

e9/l

0.27

160

746

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

755

5330

1.54

22.13

1.7

1.5

1.37

1.27

mmol/l

2.13

681

4703

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

310

1731

1.87

22.05

4.5

3.9

235.41

234.15

u/l

0.05

294

1641

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

738

5214

1.54

21.46

2.1

1.9

—

(3008295) Osmolality of Serum or Plasma

167

3.83

20.97

4.9

1.8

285.22

285.11

mosm/kgh2o

0.01

134

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

336

1955

1.80

20.90

6.2

4.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2675

24256

1.55

20.51

4.2

3.2

2.77

2.85

mmol/l

5.67

2554

23000

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2543

22826

1.50

20.34

3.6

2.8

1.25

1.13

mmol/l

11.36

2415

21648

(3011985) Renin [Units/volume] in Plasma

242

3.23

19.82

2.8

1.8

78.25

51.26

mu/l

1.00

221

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

175

828

2.18

19.77

9.1

3.9

24.27

24.03

mmol/l

0.43

169

810

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

134

571

2.40

19.38

4.6

3.3

24.72

24.59

mmol/l

0.19

127

541

(3002385) Erythrocyte distribution width [Ratio]

2683

24434

1.53

19.23

19.0

11.0

14.28

14.90

0.88

2650

23945

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

978

7460

1.44

19.03

1.6

1.4

—

(3019150) Specific gravity of Urine by Refractometry

755

5486

1.49

18.87

4.2

3.1

1.01

1.02

kg/l

0.63

118

884

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1068

8292

1.43

18.81

2.4

2.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

117

4.24

18.81

4.4

2.5

160.89

184.94

umol/l

0.19

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2647

24071

1.51

18.77

4.0

3.0

4.70

4.76

mmol/l

2.68

2536

22943

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1234

9878

1.40

18.06

4.2

3.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

267

1515

1.83

17.98

1.2

—

(3019060) Gas panel - Arterial blood

155

731

2.18

17.67

6.0

5.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2624

23930

1.47

17.28

3.9

3.0

1.54

1.55

mmol/l

1.21

2504

22780

(3009445) Proteinase 3 Ab [Units/volume] in Serum

158

760

2.13

17.14

1.6

3.80

8.28

u/ml

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

962

7432

1.42

17.07

2.3

2.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

193

1003

1.98

16.98

10.2

6.3

24.98

24.58

mmol/l

0.68

193

997

(3028707) Methadone [Presence] in Urine by Screen method

187

962

2.00

16.93

4.4

2.4

—

(40761535) Cells panel - Urine sediment

241

1355

1.84

16.71

4.8

3.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

247

1404

1.82

16.53

4.2

2.8

1.23

mmol/l

0.16

226

1215

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

633

4551

1.48

16.40

1.4

1.3

20.43

24.43

iu/ml

0.54

165

1423

(3009542) Hematocrit [Volume Fraction] of Blood

3221

31058

2.65

16.38

24.3

13.2

39.27

39.75

1.43

3089

29426

(3024666) Lithium [Moles/volume] in Serum or Plasma

239

3.01

16.34

14.0

10.8

0.66

0.59

mmol/l

2.27

221

(3020630) Protein [Mass/volume] in Serum or Plasma

194

1025

1.95

16.28

2.1

2.2

67.21

67.32

g/l

0.07

175

948

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

5.20

16.26

2.0

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

142

671

2.17

16.13

11.4

8.6

—

(3021901) Oxygen saturation in Capillary blood

226

3.05

16.00

2.3

2.5

—

(3024928) Oxygen saturation in Venous blood

308

2.74

16.00

9.6

2.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

191

1010

1.95

15.99

1.9

1.7

—

(3020891) Body temperature

107

450

2.42

15.97

6.5

4.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

133

3.72

15.84

2.5

1.7

1.93

4.71

nmol/l

0.84

111

(3029937) Albumin [Presence] in Urine by Test strip

878

6753

1.41

15.75

4.5

3.1

0.01

0.00

estimate

0.49

314

2529

(3004588) Protein electrophoresis panel - Serum or Plasma

154

758

2.08

15.75

1.8

2.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

279

1667

1.74

15.75

1.2

1.1

33.78

181.47

titre

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

595

4261

1.48

15.65

1.3

1.2

8.09

10.45

u/ml

0.48

227

1775

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

206

1127

1.88

15.57

1.6

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

587

4198

1.48

15.54

1.9

1.7

—

(3024731) MCV [Entitic volume]

3223

31160

2.57

14.94

24.0

13.2

90.15

89.73

6.30

3204

30769

(3007461) Platelets [#/volume] in Blood

3220

31121

2.52

14.88

24.1

13.2

267.49

268.86

e9/l

0.60

3176

30372

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

286

1748

1.70

14.85

2.4

2.3

19.49

20.43

au/ml

0.07

163

(3020911) Cortisol [Moles/time] in 24 hour Urine

107

3.96

14.84

1.9

1.3

114.93

81.58

nmol/24h

0.63

107

(3022145) Colonoscopy Study observation

310

1937

1.66

14.81

1.3

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

3224

31186

2.57

14.71

24.2

13.3

131.30

132.30

g/l

5.74

3205

30793

(3035941) MCH [Entitic mass]

3222

31159

2.54

14.69

24.0

13.1

29.98

29.89

2.31

3203

30768

(3026361) Erythrocytes [#/volume] in Blood

3222

31165

2.53

14.57

24.1

13.2

4.41

4.45

e12/l

6.38

3174

30382

(3010813) Leukocytes [#/volume] in Blood

3223

31180

2.54

14.55

24.1

13.2

6.68

6.82

e9/l

2.73

3174

30367

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

106

466

2.32

14.36

2.6

2.2

166.13

920.34

ug/l

0.93

416

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

137

670

2.09

14.27

11.0

8.6

24.07

24.11

mmol/l

0.04

132

649

(3008152) Bicarbonate [Moles/volume] in Arterial blood

146

732

2.04

14.23

9.0

6.4

24.03

24.26

mmol/l

0.31

140

696

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

109

487

2.28

14.22

6.2

5.4

1.79

1.65

0.63

104

457

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

418

2.39

14.22

2.1

1.9

1.19

1.98

ug/l

0.76

371

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

5.69

14.13

1.7

1.6

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

267

1624

1.70

14.11

1.3

41.71

42.98

au/ml

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

165

868

1.95

14.04

2.2

1.9

1.13

1.16

g/l

0.77

158

824

(3025941) Bacteria identified in Stool by Culture

244

1450

1.74

14.03

1.3

1.2

—

(3019225) pH of Specimen

255

1540

1.71

13.83

5.3

3.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

127

619

2.09

13.37

1.7

1.8

196.00

356.67

titre

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

164

883

1.90

13.04

2.8

99.93

138.75

ng/l

1.50

144

786

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

272

1698

1.66

13.02

3.1

2.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

159

848

1.92

13.01

2.3

1.9

0.22

g/l

0.32

151

804

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

205

2.91

12.91

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

308

2.54

12.85

1.7

5.04

5.30

mmol/24h

0.27

282

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

388

2.36

12.78

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

274

2.63

12.75

1.6

—

(1616796) Gas panel - Central venous blood

346

2.43

12.70

3.4

2.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

253

2.68

12.56

1.7

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

194

1121

1.78

12.30

1.6

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

252

1578

1.65

11.92

4.7

3.9

0.71

0.55

0.61

404

(3007566) Smooth muscle Ab [Titer] in Serum

125

633

2.01

11.90

1.4

1.3

108.57

224.46

titre

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

118

586

2.05

11.85

1.4

32790.18

998.47

e6/l

0.49

486

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

118

586

2.05

11.85

1.4

42.64

19.39

e6/l

0.53

469

(3044290) Cell count panel - Cerebral spinal fluid

112

551

2.07

11.54

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

191

1120

1.75

11.53

1.5

1.3

0.41

1.34

u/ml

1.16

(3022493) Free Hemoglobin [Mass/volume] in Plasma

4.29

11.47

1.5

5.3

6351.76

75.06

mg/l

0.48

(3036489) Thrombin time

164

922

1.82

11.41

2.7

2.0

20.36

20.94

1.36

135

777

(3014765) Yersinia sp identified in Stool by Organism specific culture

130

678

1.96

11.39

1.2

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

140

3.17

11.23

1.5

1.4

1.65

1.42

nmol/l

0.65

124

(3020876) Protein [Mass/time] in 24 hour Urine

120

3.36

11.22

2.2

2.9

1.56

1.73

g/24h

0.14

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

141

762

1.89

11.12

2.1

2.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

387

2.25

11.11

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

225

2.65

10.90

1.4

1.5

2187.80

401.68

pmol/l

0.50

202

(3007930) Methemoglobin/Hemoglobin.total in Blood

102

496

2.09

10.86

6.7

5.6

0.95

0.00

465

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

103

3.52

10.86

1.3

12.74

13.65

pmol/l

0.69

(3017181) Myelocytes/100 leukocytes in Blood

265

1719

1.59

10.85

4.9

4.1

1.13

0.79

0.98

102

471

(42529406) Shigella sp [Presence] in Stool by Culture

129

683

1.92

10.83

1.2

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

285

2.45

10.82

2.1

2.4

16.49

16.84

0.27

142

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

102

497

2.09

10.81

6.0

4.6

1.34

1.22

mg/l

0.92

470

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

310

2.39

10.78

1.3

1.4

—

110.00

—

(3045414) Leukocytes [Presence] in Urine

176

1034

1.74

10.57

1.8

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

135

732

1.88

10.56

3.2

2.4

159.84

172.72

1.01

126

692

(3018405) Lactate [Moles/volume] in Arterial blood

390

2.21

10.50

5.0

3.2

1.35

mmol/l

0.01

380

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

138

759

1.85

10.33

2.4

2.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

136

745

1.86

10.31

5.4

2.5

3.52

3.59

g/l

0.24

126

697

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

407

2.17

10.25

1.2

1.1

19.93

21477.12

iu/ml

0.52

107

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

150

852

1.80

10.12

1.6

1.7

39.63

38.53

u/l

0.32

135

802

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

4.34

10.04

3.5

2.4

29.16

26.78

umol/l

0.16

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

125

674

1.89

9.96

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

281

1884

1.54

9.96

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

123

661

1.89

9.91

1.3

413.12

430.24

mg/l

0.24

116

639

(4200892) Spirometry reversibility

198

1223

1.66

9.90

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

112

584

1.95

9.87

1.2

3.74

3.56

mmol/l

0.71

102

553

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

397

2.15

9.67

6.9

4.7

253.22

683.38

iu/ml

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

217

2.56

9.54

1.3

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

111

585

1.93

9.49

3.2

2.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

389

2.14

9.36

1.5

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1079

9101

1.28

9.31

1.9

1.7

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

9.52

9.25

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

310

2155

1.48

9.24

3.9

3.0

32.46

33.23

0.66

257

1611

(40768443) Skin Pathology biopsy report

144

833

1.76

9.16

1.3

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

119

650

1.86

9.14

1.3

28.81

46.80

u/ml

0.76

(3000093) Morphology [Interpretation] in Blood Narrative

153

2.83

9.11

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1311

11349

1.26

9.02

2.4

2.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

236

2.44

8.96

1.5

1.6

—

(3051651) Icteric interference index of Serum or Plasma

117

3.10

8.93

2.9

2.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

141

819

1.75

8.86

2.8

2.2

0.28

0.30

e6/l

0.07

135

776

(44816559) Phosphatidylethanol [Mass/volume] in Blood

104

550

1.92

8.83

1.4

1.3

—

(3025159) Blasts/100 leukocytes in Blood

238

1581

1.54

8.80

5.1

4.2

0.07

0.51

0.69

340

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

149

881

1.72

8.79

2.3

2.0

—

(3010421) pH of Blood

394

2.08

8.69

3.8

2.9

7.41

7.42

0.58

356

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

139

814

1.74

8.50

3.1

2.1

97.78

94.84

0.95

130

774

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

195

2.54

8.39

3.9

1.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

122

2.97

8.34

1.3

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

374

2.08

8.31

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

374

2.08

8.31

1.3

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

197

2.51

8.22

2.5

1.4

1.00

1.27

promille

0.57

150

(3020717) Zinc [Moles/volume] in Serum or Plasma

162

2.68

8.22

2.1

1.6

16.57

26.10

umol/l

1.71

155

(3041096) Erythrocytes [Presence] in Urine by Automated

888

7416

1.27

8.09

3.4

2.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

188

2.52

7.98

1.7

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

242

1649

1.50

7.97

5.1

4.2

0.05

0.14

0.88

402

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

165

2.63

7.94

3.5

2.8

39106.98

39302.05

ug/l

0.04

165

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

113

636

1.80

7.93

1.3

1.4

—

(3002256) Pathology report gross observation

328

2375

1.42

7.89

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

166

2.61

7.85

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

290

2.20

7.81

1.6

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

290

2.20

7.81

1.6

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

197

2.46

7.73

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

266

2.24

7.70

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

254

2.27

7.65

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

387

2.01

7.61

1.9

1.7

0.53

0.63

g/l

0.45

292

(3011288) Drugs identified in Urine by Screen method

233

1592

1.50

7.58

4.3

2.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

451

1.93

7.54

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

182

2.49

7.49

2.7

2.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

152

946

1.64

7.44

1.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

364

2.03

7.39

4.1

2.3

1.11

0.76

nmol/l

2.06

307

(3049717) Cytology report of Urine Cyto stain

239

2.28

7.37

1.7

2.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

106

599

1.80

7.37

1.4

105.28

106.46

u/ml

0.05

142

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1092

9421

1.24

7.34

1.9

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

121

712

1.73

7.32

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

164

1045

1.60

7.31

1.7

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

352

2.04

7.30

2.4

2.7

—

(3011412) CD3 cells [#/volume] in Blood

253

2.23

7.29

4.1

2.2

1.25

1.30

e9/l

0.20

214

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

121

2.83

7.26

1.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

121

2.83

7.26

1.6

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

121

2.83

7.26

1.6

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

293

2.14

7.23

1.4

—

(3017732) Neutrophils [#/volume] in Blood

245

1708

1.47

7.22

2.7

2.2

5.30

4.59

e9/l

0.27

212

1496

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

538

1.83

7.18

1.7

1.8

8.99

10.65

mg/l

1.63

512

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

431

1.93

7.16

1.2

1.1

117.85

117.28

0.06

388

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

119

702

1.72

7.14

2.3

1.8

—

(3006653) Thiamine [Moles/volume] in Blood

106

2.94

7.11

1.3

1.5

129.39

124.86

nmol/l

0.26

106

(3019420) Tryptase [Mass/volume] in Serum or Plasma

157

2.57

7.09

2.1

1.2

20.10

5.48

ug/l

0.76

136

(3036180) Methadone [Presence] in Urine

212

2.33

7.06

3.3

2.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

219

2.30

7.01

1.3

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

130

2.71

6.92

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.70

6.91

2.9

2.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

445

1.89

6.84

1.3

1.2

4.82

5.01

u/ml

0.04

189

(3026389) Candida sp identified in Specimen by Organism specific culture

389

1.95

6.82

1.3

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

130

798

1.65

6.75

1.5

1.3

18.64

35.79

u/ml

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

302

2.07

6.71

2.5

2.6

57.60

105.30

ug/min

0.66

194

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

168

2.46

6.67

1.5

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

151

2.53

6.59

1.6

1.8

3185000.00

1117747.33

iu/ml

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

189

2.35

6.47

1.4

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

113

677

1.69

6.45

1.2

279.70

255.02

u/ml

0.39

438

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

196

2.31

6.42

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

190

2.33

6.40

1.4

1.2

—

(3045424) Erythrocytes [Presence] in Urine

356

1.96

6.40

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

205

1416

1.48

6.36

2.2

2.4

86.44

79.48

ml/min/173m2

0.45

523

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

371

1.93

6.35

2.0

1.7

39.49

38.69

g/l

0.53

338

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

160

2.45

6.35

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

401

1.89

6.27

2.0

0.20

0.68

g/l

1.59

359

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

339

1.97

6.21

1.9

1.8

0.00

g/l

-0.00

315

(3048929) Epstein Barr virus Ab [Presence] in Serum

211

1474

1.46

6.18

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

245

2.14

6.16

1.2

—

(3012501) Base excess in Blood by calculation

333

1.97

6.16

4.2

2.8

2.92

2.16

mmol/l

0.72

186

(3027315) Oxygen [Partial pressure] in Blood

333

1.97

6.16

4.2

2.8

8.54

9.19

kpa

2.79

327

(3013290) Carbon dioxide [Partial pressure] in Blood

333

1.97

6.16

4.2

2.8

5.17

4.95

kpa

1.60

327

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

462

1.82

6.12

1.3

1.2

3.24

4.06

u/ml

0.18

166

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

369

1.92

6.11

1.9

1.7

0.00

g/l

0.54

341

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

246

2.13

6.10

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

266

2.09

6.10

1.9

1.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

182

2.32

6.08

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

247

2.12

6.05

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

247

2.12

6.05

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

247

2.12

6.05

1.2

—

(3023410) Appearance of Cerebral spinal fluid

301

2.01

6.04

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

343

1.94

6.02

1.9

1.8

0.00

g/l

-0.00

317

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

248

2.11

5.99

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

330

1.96

5.97

3.5

4.3

0.40

0.37

u/ml

0.32

189

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

304

1.99

5.89

2.9

4.5

78.73

91.32

u/ml

0.09

120

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

113

2.67

5.82

1.5

1.8

6.18

6.20

u/l

0.01

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

116

720

1.63

5.82

1.5

1.3

5.49

3.40

u/ml

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

167

2.35

5.81

1.7

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

247

1798

1.40

5.80

3.6

1.9

—

(4035726) Immunohistochemistry procedure

208

1468

1.44

5.79

1.4

1.3

—

(3023419) Bacteria identified in Sputum by Culture

174

2.31

5.76

2.5

3.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

279

2076

1.38

5.74

1.4

1.3

194.45

206.15

u/ml

0.11

255

1920

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

435

1.81

5.74

1.9

2.90

2.95

g/l

0.17

404

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

457

1.79

5.74

1.9

7.06

7.34

g/l

0.75

425

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

457

1.79

5.74

1.9

3.46

3.65

g/l

0.83

426

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

457

1.79

5.74

1.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

467

1.78

5.64

1.8

1.6

—

(3042631) Mycobacterium sp identified in Specimen

127

2.53

5.61

3.0

2.5

—

(3047181) Lactate [Moles/volume] in Blood

483

1.76

5.60

7.3

5.6

1.25

1.16

mmol/l

0.64

427

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

202

2.19

5.59

1.7

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

104

2.71

5.59

1.3

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

164

2.33

5.58

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

346

1.90

5.55

3.4

2.1

—

(3039000) Anion gap in Blood

297

1.97

5.54

8.4

7.7

10.98

11.18

mmol/l

0.18

272

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

2.74

5.52

5.0

2.6

45.18

48.35

0.50

(21494755) Public health laboratory ask at order entry panel

308

3993

0.75

5.50

1.2

—

(3018572) Chloride [Moles/volume] in Blood

298

1.96

5.49

8.4

7.7

103.96

105.64

mmol/l

1.16

273

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

116

731

1.61

5.49

1.5

1.3

7.14

8.60

u/ml

0.17

123

(3037121) Protein [Mass/volume] in Urine

104

639

1.65

5.45

3.8

3.1

0.45

0.47

g/l

0.06

273

(4062490) Immunoglobulin typing, IgG

265

2.02

5.42

1.7

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

587

1.67

5.39

1.4

1.3

4.28

4.37

u/ml

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

403

1.80

5.27

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

389

1.82

5.25

2.2

2.3

129.48

130.39

g/l

0.12

294

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

486

1.73

5.22

4.3

3.6

59.07

56.58

1.04

486

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

325

1.89

5.21

1.4

1.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

428

1.77

5.16

2.0

1.9

10.68

10.49

g/l

0.14

395

(40761536) Microorganisms panel - Urine sediment

306

2351

1.33

5.13

4.3

2.9

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.76

5.08

3.6

7.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

178

2.21

5.06

1.1

1.2

66.10

19.29

u/l

0.52

154

(3002079) Sodium [Moles/time] in 24 hour Urine

104

2.61

5.05

1.6

1.2

129.74

141.61

mmol/24h

0.55

104

(3001186) Copper [Moles/volume] in Serum or Plasma

3.18

5.03

2.4

1.7

14.64

17.45

umol/l

1.49

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

180

2.18

4.93

1.4

1.3

203.33

187.33

titre

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

202

2.09

4.80

4.6

2.2

507.74

504.36

e6/l

0.02

163

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

11.45

4.78

2.5

2.0

—

(3016879) Cocaine [Presence] in Urine

278

2129

1.33

4.78

3.5

1.8

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

264

1.95

4.78

1.8

1.5

0.33

0.39

g/l

1.02

182

(3028192) IgG subclass 2 [Mass/volume] in Serum

264

1.95

4.78

1.8

1.5

2.52

3.03

g/l

1.70

183

(3027135) IgG subclass 1 [Mass/volume] in Serum

265

1.94

4.73

1.8

1.5

6.62

6.71

g/l

0.07

184

(3028433) Virus identified in Specimen by Culture

2.80

4.71

1.4

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

218

2.03

4.66

1.1

1.2

1.05

ratio

0.03

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.22

4.61

2.1

1.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

199

2.07

4.59

1.7

3.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

200

2.06

4.53

3.0

2.1

45.05

43.36

0.32

200

(3011648) Oxygen content in Venous blood

117

2.41

4.47

11.9

2.5

11.28

10.66

0.29

117

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

343

1.79

4.45

1.1

—

64.88

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.93

4.44

3.2

2.7

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

202

2.04

4.42

1.5

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

202

2.04

4.42

1.5

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.69

4.41

1.0

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

4.07

4.40

4.7

4.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

118

2.38

4.39

1.3

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.62

4.39

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.62

4.39

1.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

150

2.21

4.36

2.5

2.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

331

1.80

4.35

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2585

24798

1.20

4.28

4.2

3.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

275

1.87

4.27

1.7

3.3

44.55

54.07

mg/l

0.23

235

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

108

2.42

4.22

1.2

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

144

1011

1.44

4.21

1.1

1.74

6.30

u/ml

2.18

168

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.27

4.18

1.3

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

630

1.56

4.13

2.4

2.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

202

1.99

4.06

4.8

2.2

0.19

0.20

e9/l

0.03

163

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

251

3207

0.76

4.03

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

111

2.35

3.99

1.1

0.11

4.24

nmol/l

—

(3040151) Glucose [Moles/volume] in Capillary blood

218

1.94

3.96

5.9

3.3

7.20

6.41

mmol/l

0.61

177

(3008757) Leukocyte morphology finding [Identifier] in Blood

170

2.07

3.95

2.5

2.9

—

(3000330) Specific gravity of Urine by Test strip

139

984

1.43

3.91

3.8

2.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

277

1.82

3.88

1.7

3.2

34.78

40.08

mg/l

0.17

235

(3006442) Creatine [Moles/volume] in Serum or Plasma

126

2.23

3.83

1.9

1.2

71.00

70.02

umol/l

0.07

126

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.43

3.80

1.2

114.35

117.14

0.15

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

279

1.80

3.79

1.1

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.48

3.79

1.2

1.1

95.69

98.78

0.16

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

243

1.86

3.79

2.0

2.1

9.58

1045.85

u/ml

0.50

243

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

3.19

3.77

1.1

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

140

2.15

3.76

1.1

—

(4034850) Laboratory test

101

678

1.51

3.73

9.7

5.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

266

1.82

3.73

1.7

3.2

1.29

1.88

ratio

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.65

3.72

1.4

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

115

2.27

3.70

1.2

1.1

0.30

0.29

g/l

0.22

(3016650) Hepatitis A virus Ab [Presence] in Serum

433

1.63

3.69

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

5.01

3.68

2.6

2.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

210

1.92

3.67

1.1

1.3

1.82

1.89

mmol/l

0.23

194

(3004616) Nuclear Ab [Presence] in Serum

275

1.79

3.66

1.5

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.38

3.64

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.48

3.63

2.0

2.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

321

1.73

3.60

2.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

177

1.99

3.58

1.2

—

(3022621) pH of Urine by Test strip

207

1588

1.32

3.58

2.9

2.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

110

759

1.46

3.57

1.2

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.40

3.55

1.2

1.1

91.92

94.81

0.21

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.40

3.55

1.4

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

227

1.86

3.55

1.3

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

111

2.26

3.54

5.2

1.9

116.67

235.25

e6/l

1.18

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

10.02

3.49

1.8

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.62

3.49

1.2

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.62

3.47

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

132

2.13

3.45

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

2.35

3.40

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.08

3.39

1.4

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

4.08

3.39

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

288

2325

1.26

3.38

3.5

1.8

—

(3028300) Cannabinoids [Presence] in Urine

290

2344

1.26

3.37

3.5

1.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

255

1.78

3.29

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.48

3.29

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.54

3.29

1.4

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

115

2.18

3.28

1.4

5033.53

77619.88

e6/l

0.52

(21494434) Karyotype in Bone marrow

109

2.21

3.25

1.3

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

271

1.74

3.25

1.4

1.2

—

0.54

nmol/l

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.67

3.22

1.6

4.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.34

3.22

1.9

1.2

—

(1002224) Polysomnography panel

122

877

1.41

3.21

1.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.44

3.21

1.2

—

(3027008) Opiates [Presence] in Urine

288

2341

1.25

3.20

3.5

1.8

—

(3023420) DNA double strand Ab [Units/volume] in Serum

327

1.66

3.14

2.1

1.8

38.80

27.35

iu/ml

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.38

3.05

1.2

—

(3045142) Bone marrow Pathology biopsy report

139

2.02

3.05

1.5

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.31

3.00

1.8

1.3

—

(3003338) MCHC [Mass/volume]

2603

25187

1.16

3.00

20.4

11.2

331.67

332.05

g/l

1.51

2588

24950

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

4.29

2.99

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

10.01

2.98

1.4

3.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

10.01

2.98

3.0

3.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

205

1.81

2.94

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.28

2.93

1.1

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.45

2.89

1.0

1.8

4.34

221748.43

nmol/l

0.48

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.39

2.87

1.1

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

151

1.93

2.79

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

346

1.60

2.79

1.8

1.6

2644.20

10569.57

e6/l

3.79

255

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.65

2.79

1.3

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.65

2.79

1.3

1.2

—

(3027944) Amphetamines [Presence] in Urine

281

2316

1.23

2.78

3.4

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

173

1.86

2.76

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

8.34

2.75

3.4

5.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

8.34

2.75

1.0

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

188

1.82

2.74

1.2

14.00

21.45

u/ml

—

(3042733) HLA Ab [Presence] in Serum

2.60

2.70

4.3

4.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

118

873

1.36

2.67

2.0

2.1

184.13

4.37

iu/l

0.75

387

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

528

1.47

2.66

1.1

2.04

2.96

u/ml

0.68

299

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

161

1.87

2.66

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1137

10510

1.12

2.63

1.8

—

(3022689) Creatine [Moles/volume] in Urine

2.66

2.62

1.2

1.8

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

236

1.70

2.61

1.5

1.2

—

nmol/l

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

237

1.70

2.57

1.3

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.30

2.57

1.9

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.30

2.57

1.9

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

262

2163

1.23

2.57

1.3

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

370

1.55

2.56

5.7

2.9

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

230

1.70

2.55

1.6

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

113

837

1.36

2.55

1.3

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.86

2.54

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.86

2.54

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.86

2.54

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.86

2.54

1.3

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.43

2.53

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

223

1.71

2.53

1.7

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

231

1.70

2.52

1.7

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

224

1.70

2.50

1.7

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

221

2697

0.81

2.48

1.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.47

2.48

1.7

2.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

3.82

2.46

1.0

11.86

14.72

pmol/l

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.39

2.46

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.39

2.46

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

144

1.88

2.46

2.7

2.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

173

1370

1.28

2.45

1.7

1.6

4.12

4.07

mg/l

0.04

126

934

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

233

1.68

2.45

1.7

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

123

930

1.34

2.45

1.5

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.24

2.44

1.9

1.8

—

(3000012) Reticulocyte production index

145

1.87

2.41

2.3

2.0

—

(3037756) Immunofixation for Serum or Plasma

189

1.75

2.41

1.4

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

235

1.67

2.38

1.3

1.6

—

(3024932) HLA-DR beta [Type]

2.42

2.36

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

2.09

2.32

1.5

1.6

—

(3024471) HLA-A [Type]

2.38

2.29

1.1

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

223

1.67

2.27

1.7

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.62

2.27

2.2

1.9

—

(3044927) Protein electrophoresis panel - Urine

2.03

2.26

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.89

2.25

2.6

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

5.56

2.21

1.0

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

249

2962

0.83

2.19

1.6

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

2.30

2.14

1.0

1.3

105.86

102.21

0.21

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.78

2.13

1.1

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

130

1.85

2.12

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

413

1.46

2.10

1.8

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

308

1.53

2.08

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

110

1.91

2.05

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

185

2249

0.81

2.04

1.3

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

314

0.51

2.03

1.5

1.6

5.21

5.02

mmol/l

0.46

306

(3024869) Neuronal Ab [Presence] in Serum

3.08

2.01

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

193

1.66

1.99

2.6

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

126

1.83

1.98

3.9

2.9

121.75

61.13

mg/l

0.24

(3042517) Benzodiazepines panel - Urine

2.29

1.97

2.4

2.3

—

(4146454) Self-monitoring of blood glucose

105

1.91

1.95

2.1

2.9

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

172

1.69

1.93

1.4

1.2

—

65.22

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

634

1.35

1.92

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.25

1.90

1.2

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

2.01

1.90

1.1

1.3

—

74.29

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

189

1.65

1.87

1.2

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.86

1.86

1.1

1.4

14.11

13.45

g/l

—

(3038026) Centromere Ab [Units/volume] in Serum

174

1.67

1.86

1.4

1.3

—

63.13

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

683

0.68

1.85

1.4

1.6

7.12

6.38

mmol/l

1.25

622

(3014148) Varicella zoster virus Ab [Titer] in Serum

622

1.34

1.83

1.3

1.2

—

(3000285) Sodium [Moles/volume] in Blood

4.17

1.82

2.2

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.13

1.81

1.9

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

191

1.63

1.80

2.1

14.75

23.74

mg/l

1.24

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

444

1.40

1.80

3.7

313.63

351.90

u/ml

0.05

369

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.58

1.80

1.9

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.05

1.80

5.3

5.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.76

1.79

1.4

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

370

1.44

1.77

1.4

—

(4281824) Cell count and differential, peritoneal fluid

185

1.63

1.75

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

405

1.41

1.74

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

448

1.39

1.72

1.2

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.92

1.72

1.3

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.85

1.71

1.0

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

177

0.45

1.69

1.6

1.2

1.56

1.61

g/l

—

177

(3019174) dRVVT (LA screen)

2.58

1.66

1.3

1.2

—

(40765096) Chromosome analysis panel by Banding

2.58

1.66

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

2.58

1.66

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

2.58

1.66

2.3

2.1

—

(3044941) Cell count panel - Synovial fluid

244

1.52

1.65

1.6

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

212

1.56

1.65

1.0

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.44

1.64

1.1

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

120

1.75

1.62

1.2

1.1

—

(3017509) Phencyclidine [Presence] in Urine

2.15

1.61

3.1

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

143

1.68

1.61

1.5

1.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.91

1.59

1.1

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

501

4541

1.12

1.58

2.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.33

1.58

1.3

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.70

1.58

22.1

7.2

—

(3020393) Adenovirus Ag [Presence] in Stool

2.70

1.58

1.9

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.28

1.55

1.0

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.43

1.53

4.4

4.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.43

1.53

4.4

4.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.34

1.52

1.0

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.86

1.50

1.4

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

925

8674

1.09

1.50

1.8

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.23

1.46

1.1

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

310

1.43

1.45

1.1

224.32

200.94

mg/l

0.38

274

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.50

1.45

24.0

6.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

211

1814

1.17

1.45

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.12

1.44

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

2.73

1.43

1.2

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.31

1.43

1.0

1.2

—

(3034426) Prothrombin time (PT)

110

1.73

1.42

1.1

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

321

1.41

1.40

1.2

1.1

43.99

35.00

mg/l

0.52

266

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.18

1.40

2.3

3.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.18

1.40

1.6

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

134

1.65

1.39

1.2

—

(3006462) Nitrate [Presence] in Urine

111

1.72

1.39

2.3

2.2

—

(3017704) Immunofixation for Urine

2.08

1.38

1.0

1.5

—

(3044007) Cell count panel - Peritoneal fluid

2.20

1.37

2.6

1.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

256

1.45

1.36

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

136

1.62

1.32

1.3

—

(3020491) Glucose [Moles/volume] in Blood

185

1.52

1.29

1.6

5.70

5.74

mmol/l

0.04

153

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

145

1.59

1.28

1.4

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.78

1.28

1.2

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.40

1.24

2.0

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.04

1.22

1.2

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.63

1.21

2.0

3.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.63

1.21

1.2

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

144

0.49

1.20

1.7

1.2

—

(3004451) EKG impression Narrative

2.11

1.18

1.3

1.2

—

(3033799) Differential panel - Peritoneal fluid

2.05

1.15

1.6

1.8

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

260

0.61

1.15

1.2

—

(3013466) aPTT in Blood by Coagulation assay

2.50

1.15

1.0

1.1

38.72

35.88

—

(3010937) Rubella virus Ab [Presence] in Serum

2.00

1.12

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.96

1.11

1.3

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.26

1.10

1.6

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

140

0.50

1.08

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.87

1.07

1.0

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.93

1.06

1.2

1.1

—

153.33

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

211

1.43

1.06

1.1

12.92

5.46

iu/ml

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

137

1.54

1.05

1.7

1.8

1.23

2.01

u/field

0.83

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.06

1.03

1.3

1.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.74

1.02

3.8

2.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

171

1.47

1.02

1.1

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

466

1.27

1.00

1.3

1.2

—

(3020650) Glucose [Presence] in Urine

1.71

0.98

1.4

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

224

1.39

0.96

1.3

1.2

1.12

2.27

u/ml

0.41

123

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

208

1.40

0.94

1.2

1.1

1.01

0.98

u/l

0.18

(4094501) Cardiovascular stress test using bicycle ergometer

295

1.33

0.92

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.72

0.92

1.4

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.63

0.90

1.0

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

118

1.53

0.90

2.8

2.6

20.47

87.78

ug/l

0.54

110

(3035933) Granulocytes/100 leukocytes in Blood

111

1.53

0.87

1.1

2.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

148

1298

1.15

0.87

2.9

4.0

4.73

48.25

ug/l

0.87

106

952

(3034274) Bile acid [Moles/volume] in Serum --fasting

131

1139

1.16

0.87

2.1

2.3

5.32

4.79

umol/l

0.26

840

(3032868) Hemoglobin electrophoresis panel in Blood

2.00

0.87

1.7

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

550

1.22

0.85

1.2

1.1

11.13

10.70

au/ml

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

300

1.30

0.84

1.3

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

656

0.80

0.83

2.2

13.08

13.07

0.04

644

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

355

1.27

0.81

1.3

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

472

1.23

0.81

1.4

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

172

1.40

0.80

2.3

3.1

3.24

5.50

nmol/l

0.75

164

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

226

2049

1.11

0.80

1.4

1.3

201.27

239.28

miu/ml

0.90

103

1068

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.77

0.0

8.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.70

0.75

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.57

0.75

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.08

0.74

1.2

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

784

0.84

0.71

1.8

—

(3011436) Histone Ab [Units/volume] in Serum

1.75

0.71

1.3

1.1

—

(3048879) Bone marrow aspiration report

1.85

0.68

1.2

2.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.67

0.68

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

204

0.68

1.1

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

402

1.22

0.66

1.7

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

294

1.26

0.66

1.0

1.1

0.22

2.01

u/ml

1.28

105

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.79

0.66

1.0

1.1

—

(40768446) Kidney Pathology biopsy report

1.54

0.65

1.3

1.6

—

(3012441) Differential panel - Pleural fluid

1.54

0.65

1.4

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

180

1.34

0.65

2.0

2.2

—

(3051101) Glucose [Moles/volume] in Cord blood

1.73

0.64

3.0

4.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.67

0.61

1.4

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.48

0.60

1.2

1.1

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.60

0.0

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.57

0.60

2.0

5.6

—

(3002619) Bacteria identified in Specimen by Culture

1.57

0.60

1.1

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

323

3026

1.07

0.59

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

491

1.18

0.59

3.8

2.9

18.53

24.55

mg/l

0.95

289

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

560

5860

0.95

0.57

1.6

1.5

—

(40768806) Pleura Pathology biopsy report

1.48

0.57

1.2

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

1.67

0.56

9.0

6.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

522

1.17

0.56

2.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.62

0.55

7.3

4.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

209

2259

0.92

0.55

1.6

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

239

1.26

0.55

1.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.58

0.54

7.5

4.4

17.98

24.06

mg/l

—

(3035880) pH of Pleural fluid

1.54

0.53

1.5

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

323

3045

1.07

0.52

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.41

0.51

1.2

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

323

3047

1.07

0.51

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

322

3040

1.07

0.50

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

840

1.12

0.49

1.1

3.86

5.89

u/ml

1.26

477

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

1.56

0.49

1.1

1.2

9.14

10.00

u/l

—

(3008898) HLA-B27 [Presence]

154

1416

1.09

0.48

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.46

0.46

3.3

1.8

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.46

0.46

1.7

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

111

1.35

0.46

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

192

1.25

0.44

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.61

0.43

1.4

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.61

0.43

1.2

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.56

0.42

1.2

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

794

1.11

0.41

1.1

0.88

1.31

u/ml

0.37

363

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.43

0.41

1.2

1.0

—

(40768441) Liver Pathology biopsy report

167

1.26

0.41

1.6

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

510

1.14

0.41

1.3

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

0.41

0.0

3.6

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.41

0.0

3.6

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

16.48

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.05

—

(3007463) Buprenorphine [Presence] in Urine

1.47

0.40

2.2

4.1

—

(3005033) Fetal Nuchal fold Thickness US

263

2490

1.06

0.40

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

159

1.26

0.40

6.5

7.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

854

1.10

0.40

1.5

0.10

18.76

iu/ml

0.50

179

(3047352) Trisomy 18 risk [Likelihood] in Fetus

263

2494

1.06

0.38

1.5

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.38

0.38

1.2

0.01

0.37

u/ml

1.34

(3009871) Measles virus Ab [Titer] in Serum

1.35

0.38

2.0

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.33

0.37

1.1

1.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.31

0.37

1.2

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.35

0.37

1.0

—

(40768793) Breast Pathology biopsy report

745

0.90

0.36

1.3

—

(3024263) Appearance of Synovial fluid

1.27

0.36

1.2

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

376

3916

0.96

0.36

1.4

—

(1761868) Lipid panel - Serum or Plasma

951

9722

0.97

0.35

2.4

2.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

267

2545

1.05

0.34

1.6

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

643

1.11

0.34

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

643

1.11

0.34

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.30

0.33

3.2

2.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

220

0.82

0.32

3.6

4.5

25.58

36.93

u/ml

0.69

220

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

143

1523

0.94

0.31

1.1

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

103

955

1.08

0.31

1.1

2.51

2.46

u/ml

0.01

490

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.30

0.26

1.2

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.30

0.26

1.2

1.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

141

1.21

0.26

1.5

1.7

31.90

45.59

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.22

0.25

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.22

0.25

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.22

0.25

1.0

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

0.72

0.24

1.3

1.7

—

5.32

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.32

0.23

1.0

—

(3017569) Oxygen content in Arterial blood

1.22

0.22

3.6

2.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.21

0.0

2.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

333

3239

1.03

0.20

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.21

0.17

2.9

3.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.13

0.17

3.4

1.5

—

(3045788) Cell count panel - Pleural fluid

0.75

0.15

1.5

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

276

0.91

0.15

1.1

1.0

0.15

0.49

u/ml

—

(40768795) Lymph node Pathology biopsy report

197

1.12

0.15

1.3

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

363

1.08

0.13

1.5

1.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

233

2274

1.03

0.13

1.7

1.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

806

0.95

0.13

1.6

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

650

0.95

0.11

1.0

1.1

4.06

6.24

u/ml

0.66

287

(3010726) Horse dander IgE Ab [Units/volume] in Serum

823

0.96

0.11

1.1

1.62

2.03

u/ml

0.19

430

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

818

1.04

0.11

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

156

0.90

0.10

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

271

1.07

0.09

1.4

1.3

—

(40758292) HTLV I+II Ab panel - Serum

1.09

0.09

1.2

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

299

0.94

0.09

1.1

1.0

93.97

0.54

u/ml

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

523

5177

1.01

0.08

1.5

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

157

1.08

0.07

1.0

5.22

14.60

u/ml

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

237

1.06

0.05

1.2

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

555

0.97

0.04

1.1

0.19

0.20

u/ml

—

150

(3003434) Protein [Mass/volume] in Pleural fluid

101

1.09

0.04

1.3

36.95

33.15

g/l

0.59

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

513

0.97

0.04

1.1

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

200

0.95

0.03

1.6

1.7

32.10

48.89

—

124

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

260

0.96

0.03

1.4

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

539

1.02

0.03

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

142

1.06

0.02

1.1

0.35

2.94

u/ml

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

698

0.99

0.01

1.0

1.1

5.60

5.06

u/ml

0.05

351

(3029396) Erythrocyte agglutination [Presence] in Blood

267

0.97

0.01

2.9

3.2

—

(3000492) Spirometry study

241

2401

1.00

0.01

1.5

1.3

—

(3015183) Erythrocyte sedimentation rate

184

1.03

0.00

1.2

1.1

—

(44813793) Dust mix specific IgE antibody measurement

254

1.02

0.00

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

150

1494

1.00

0.00

2.0

—

(3021788) Differential panel - Synovial fluid

299

1.00

0.00

1.5

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

206

1.02

0.00

1.1

1929.43

1431.89

miu/ml

0.91

206

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

106

1.04

0.00

3.5

4.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

117

1.03

0.00

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.88

0.00

2.2

1.4

12.03

8.15

ug/l

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.4

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

2.4

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

311.60

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3025966) Peach IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

1.83

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.2

—

73.20

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.9

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

-0.00

0.0

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(4212803) Bone marrow aspirate examination

0.00

-0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.91

-0.00

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

130

1.00

-0.00

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_AMENORRHEAPRIM and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_AMENORRHEAPRIM	2.788 [2.41, 3.22]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.011

During the follow-up period (1.1.1998 — 31.12.2019), 506 out of 17416 females with N14_AMENORRHEAPRIM died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_AMENORRHEAPRIM.

N-year risk	Females	Males
1	0.183%	No data
5	1.321%	No data
10	3.559%	No data
15	6.383%	No data
20	11.133%	No data

Relationships between endpoints

↥

Index endpoint: N14_AMENORRHEAPRIM – Amenorrhoea

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Amenorrhoea

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints